View Article

Abstract

Microneedle system is a type of new generation transdermal drug delivery systems (TDDS) which eliminate the main disadvantages of drug administration through the skin. This paper undertakes a review of the development of the microneedle technology which has been developed as a non-invasive procedure in drug delivery across the skin because it reduces the effectiveness of the first barrier to penetration, the stratum corneum. One improved characteristic of microneedles is that they span several wells yet their size makes them permeable to water and small molecule drugs therefore providing more efficient transport to deeper skin layers.Based on both the configuration and composition, there are numerous classifications of microneedles such as solid, hollow, coated, dissolvable and hydrogel-forming microneedles. Solid microneedles are mainly employed in rendering transient poration of the skin through which drugs can diffuse while hollow-needle delivery systems dispense controlled volumes of liquids into the skin. In dissolvable microneedles, which are composed of biodegradable materials, deliver drugs and then disintegrate. Hydrogel microneedles be exude interstitial fluid in order to form drug delivery.Techniques in the fabrication of microneedles include micromolding, laser ablation and atomized spraying for etching microneedles with specific dimensions and drug holding abilities. The advancement shown here has expanded the uses of the microneedle not limited to drug delivery but in vaccination, cosmetic dermatology, and diagnostic devices.This paper also considers the benefits of using microneedle systems including improved patient compliance, little or no pain, and better drug bioavailability especially for compounds with low oral absorbability or those which require duration release. Nevertheless, some problems are still pressing, for example, the problem of potentially incompleted medicament delivery to the deeper layers of the skin because of differences in the skin characteristics and certain probability of the irritation or allergic reactions. Overall, microneedle technology's proactive and personalized approach promises to significantly enhance drug delivery, surpassing the limitations of traditional methods. Further advancement could bring better management of a multitude of diseases and health problems affecting man.

Keywords

Microneedle System, non-invasive drug administration, drug bioavailability.

Introduction

Transdermal drug delivery systems (TDDS) are Constructed to produce therapeutically effective doses of medication through the skin. Traditional multi-dose medication methods often encounter issues such as poor bioavailability due to Pre-systemic metabolism, which TDDS effectively bypasses. The design goal for transdermal products is to optimize drug flux through the skin into the bloodstream while reducing drug retention and metabolism within the skin itself. TDDS are autonomous, individual dosage forms that, when applied to unbroken skin, deliver the drug at a controlled rate into the bloodstream. This method of administration is considered a suitable option for both localized and generalized drug delivery. Transdermal delivery not only allows for a steady and controlled release of medications but also supports continuous administration of drugs with short half-lives, avoiding the fluctuations in blood levels that can lead to side effects. Other innovative methods, like Prolonged release and Mucocutaneous systems, work alongside TDDS to enhance treatment effectiveness and safety (1).

Merits:

Transdermal drug delivery systems (TDDS) offer a convenient and safe method for administering medications.

  • Key benefits of using this route for systemic drug delivery include (2) :
  • Bypassing First-Pass Metabolism 
  • Avoiding Gastrointestinal Issues
  • Predictable and Prolonged Action Reduced Side Effects 
  • Utilization of Drugs with fast clearance
  • Reduced Variability 
  • Consistent Plasma Concentration 
  • Ease of Therapy Termination 
  • Improved Patient Compliance Selective Drug Delivery ? Self-Administration.
  • Increased Therapeutic Efficacy

 Demerits:

Transdermal drug delivery systems (TDDS) have several limitations, including (1) :

  • Infeasibility for Large Doses  ? High Blood Level Requirements  ? Potential for Irritation.
  • Extensive Skin Metabolism 
  • Unfavourable Partition Coefficient 
  • Requirement for Potent Drugs

Cutaneous Physiology  

Skin is Most expansive tissue and it depth varies across different areas of the body, influenced by the depth of both the outer and inner layers. The most substantial skin thickness is located on the hairless areas of the hands and feet, where an extra layer called the stratum lucidum is found in the outermost skin layer. Conversely, areas without this layer are categorized as having thinner skin. The skin on the back is particularly thick, primarily due to a strong outer layer. However, despite its protective purpose, the skin is susceptible to a range of reddened and contagoius ailments. Furthermore, issues concerning wound recovery, changes in sensation, and aesthetic outcomes are significant in operative settings. A thorough grasp of the skin’s structure and function is crucial for effectively managing conditions in all medical fields (3).

 Structure Of Skin (3)

 1. Outermost Layer:  

The outermost layer of the skin, called the epidermis, is made up of several layers and different types of cells that play crucial roles in its function..

 Parts Of Outermost Layer  

The epidermis consists of several layers, arranged from deepest to most superficial: Layer basale, Layer spinosum, Layer granulosum, Layer lucidum, layer corneum. The innermost layer of the epidermis, the basal layer, is connected to the underlying dermis by a specialized layer called the basement membrane. This connection is strengthened by structures called hemi desmosomes. This layer contains cube shape stem cell that are growing and continuously generating keratinizing cells, along with pigment producing cells. The spinous layer consists of 8 to 10 layers of irregular, facetted cells that feature , cellularprocess often referred to as spines. These projections connect with adjacent cell through Intercellular bridges. This layer contains antigen-presenting cells. The granular layer consists of 3 to 5 layers of Rhombic cells  that contain Epidermal granule and Lipid-rich body.The Proteinrich granules hold Pre-keratin protein that aggregate and Interlink to form Cluster while the Lipid-rich body release glycolipids onto the cell membrane, acting as an adherent to ensure Intercellular adhesion. The clear layer, consisting of two to three layers of cells, is only present in thicker skin, like that on the palms and soles Eleidin, a derivative of keratohyalin, is found within this thin, translucent layer. The uppermost layer of the skin, the outermost layer of the epidermis, consists of 20 to 30 layers of tough, keratinized squamous cells. "The thickness of this layer varies, especially in areas with hardened skin Squamous cells in the stratum corneum secrete protective substances that contribute to the body's first line of defense."

 Cell Of Outermost Layer

The epidermis contains several types of cells, including keratinizing cells, Pigment cells, dendritic cells, and Tactile cells. Keratinizing cells are the predominant in the outermost skin layer, originating from the bottom layer. They create Keratinous protein and  Fatty substances that are essential for constructing the skin's waterproof barrier. Keratinizing cell also help control calcium levels by absorbing ultraviolet B radiation, which is necessary for activating vitamin D. Pigment-producing cell originate from specialized embryonic cells and are mainly responsible for producing melanin, the primary pigment in the skin. Found among the cells of the bottom layer of the epidermis, melanocytes increase pigment production in response to ultraviolet B radiation, shielding the skin from further UV damage and serving as a natural sunblock. Pigment is created by converting  4Hydroxyphenylalanine to a related compound using the enzyme monophenol oxidase. Pigment particles then move through lengthy extensions that link melanocytes to nearby keratinizing cell, transferring into their cytoplasm through a process called cytocrine transfer. In this process, keratinizing cell envelop the ends of these extensions. Epidermal dendritic cells are tree-like cells that act as the skin's initial  defense mechanism and are crucial for foreign substance display.Specific staining methods can pinpoint these cells in the spiny layer. They originate from CD34-stem cells and are part of the Reticuloendothelial System (RES). Epidermal dendritic cells possess tennis racket-shaped organelles  and exhibit Human leukocyte antigen (HLA) class I and II molecules. These cells capture foreign substances in the skin and transport them to the lymph nodes. Tactile cells are  ovate, modified skin cells situated in the basal layer, just above the basement membrane. These cells act as sensory receptors for gentle touch and are primarily located in the palms, soles, and Mucus-lined tissues with the highest concentration in the fingertips. Tactile cells form connections with nearby skin cells through Maculae adherentes  and contain intermediate keratin fibre. Their cell membranes interact with sensory nerve endings in the skin.

  • Middle Layer: 

The middle layer, which is attached to the outer skin layer by the basal lamina, comprises two layers of supporting tissue: the superficial layer and the reticular layer, which merge without clear divisions. The superficial layer, situated above, is more slender and consists of aerolar tissue that interfaces with the epidermis. Conversely, the reticular layer is the more substantial, lower layer, composed of dense irregular connective tissue with collagen  bundles and a reduced number of cells. The middle layer encompasses a variety of structures, including Sudoriferous glands, Pilosebaceous units, muscles, sensory nerves, and vasculature.

  • Innermost Layer:

The innermost layer, also known as the subcutaneous fascia, is located below the middle layer . This layer contains ,Fat tissue clusters, sensory nerves, Vasculature, and a restricted number of skin structure, such as Pilosebaceous units.

  • Role (3)

The skin's diverse functions highlight its intricate nature and crucial role in maintaining general health and wellbeing. These roles are detailed below.

  • Protective Role: The skin plays a multifaceted protective role, shielding the body from various external hazards. It regulates water balance, safeguards against microbial invasion, and protects against physical, chemical, and ultraviolet radiation damage. The plasma membrane composed of non-water soluble proteins within the plasma membrane forms the cutaneous water barrier. This barrier is constructed by the interlinking of small proteins abundant in proline. Mega proteins, such as cystatin, desmosomal plaque protein, and corneocyte protein, enhance the barrier's structural integrity. The lipid bilayer, a water-repellent layer on the cell membrane's outer surface, is necessary. Skin cells in the spiny layer of the epidermis generates protein-rich granules and membrane bound vesicles which contain lipids synthesized in the golgi bodies.These lamellar bodies release their contents into the spaces between the granular layer of the epidermis and cornified layer.

Host Defence: The skin serves as a critical component of both adaptive and non-specific immunity. In adaptive immunity,APCs stimulate T-cells mediated immunity, leading to the activation of diverse CD4+ T cells, including TH1, TH2, and TH17. Regarding non-sepcific immunity, the skin produces various polypeptides possessing Bacteriostatic Or Bactericidal and Mycostatic Or Mycotoxic capabilities. Skinassociated lymphatic tissue is a vital part of the immunuty, aiding in the infections, especially considering that even minor skin wounds can result  in infections. Dendritic cells are essential to the adaptive host response, as they present foreign antigens encountered on the skin to T lymphocytes.

Homeostasis Control: The skin plays a vital role in regulating the body's temperature and hydration levels. It helps to maintain a stable internal environment by controlling thermal exchange with the external world, primarily through its Blood conduits and Sudoriferous glands. Moreover, the skin regulates the rate and extent of Desiccation and Absorption.

Humoral Regulation and Ducted Secretion: Skin cells play a vital role in vitamin D production when exposed to sunlight. They also have the necessary components to activate this vitamin, which is essential for their growth and development. The skin's external secretion functions helps to maintain body temperature and protect the skin through the production of sweat and oil.

Sensory Roles: The skin has specialized nerve units that allow us to feel things like touch, temperature (hot and cold), and pain. This helps us interact with our surroundings. These sensory abilities are essential for our motion, safety, and communication with the world.

Diagnostic Marker: The appearance of the skin, including its color, texture, flexibility, and firmness, can provide important clues about a person's general health. Examining the skin is a common part of a physical checkup.

Absorption Of Drugs Through Transdermal Route (4)

The transdermal method of delivery offers several benefits above traditional methods like oral or injectable treatments for various diseases and cosmetic applications. The skin serves as a reservoir, allowing for prolonged and sustained release of the delivered drug. This method can minimize hazardousness and local annoyance by utilizing multiple absorption sites and helps to avoid systemic adverse effects. But, the effectiveness of delivery by transdermal is often limited, as only a few drugs can be effectively administered at viable rates through this route. The stratum corneum acts as a significant barrier, hindering the penetration of most drugs. Fortunately, non-invasive techniques have been developed to enhance drug absorption through this barrier. Recently, the use of nano carriers has emerged as a promising alternative for expanding the selection of medication appropriate for transdermal administration. These nanocarriers can facilitate the delivery of both lipophilic and hydrophilic drugs across the stratum corneum, allowing for either localized or generelized effects to address various health conditions.

Drug Penetration Pathway Through the Skin (4)

Numerous studies have investigated how topical compounds penetrate the skin. For a medication to permeate the skin effectively, it must diffuse through the retained epidermis. Human skin contains sweat glands and hair follicles, which create additional pathways for drug absorption, constituting about 0.1% of the skin's total area. The stratum corneum regulates drug penetration, and two primary pathways are identified: transcellular and intercellular routes

 The penetration of drugs through the skin can occur through two main pathways:

 Lipid Pathway:

This pathway involves the diffusion of drugs through the lipid-rich stratum corneum, the outermost layer of the epidermis.

Lipophilic drugs, which have a high affinity for lipids, can easily penetrate this barrier.

The rate of penetration depends on the drug's lipophilicity and the thickness of the stratum corneum.

 Transcellular Pathway:

This pathway involves the diffusion of drugs through the cells of the epidermis.

Hydrophilic drugs, which have a high affinity for water, can penetrate through the intercellular spaces between cells.

The rate of penetration depends on the drug's hydrophilicity and the tightness of the intercellular junctions.

Medicine Characteristics and Cutaneous Insertion (4)

Cutaneous drug delivery is influenced by the physical and chemical characteristics of the medication and the skin's condition. Critical factors impacting absorption include the daily intake, molecular size, lipid solubility , and fusion point. Ideally, the daily intake should be 20 milligrams or less, the molecular size should be below 500 Daltons, the Lipophilicity index should be between 1 and 3, and the fusion point should be below 200 degrees Celsius. Additionally, medications for skin-absorbed delivery must be non-irritating and non-allergenic.  Biological membranes typically consist of a fat-loving part with a water-loving part.  The movement of medications across biological membranes can be explained by Diffusion equation:

“J=P×CaqJ = P \times C_{aq}J=P×Caq”

Where,

J = Rate of drug movement through the membrane 

P = Partition coefficient

C= Concentration of drug 

The permeation coefficient is determined by:

“P=D×KhP = \frac{D \times K}{h}P=hD×K”

Where,

C= Diffusion coefficient of drug

K = Partition coefficient

H = Membrane thickness 

The 'diffusion rate' can be estimated using the "Stokes-Einstein" equation :

“P=RT6πηrNP = \frac{RT}{6 \pi \eta r N}P=6πηrNRT”

Where,

  • R = Ideal gas constant
  • T = Absolute temperature
  • η = Membrane viscosity
  • R = Radius of drug molecule
  • N = Avogadro's number

This equation shows that a drug must be somewhat water-soluble while also being fat-soluble to pass through the membrane. The “Stokes-Einstein equation” also suggests that smaller molecules can permeate more easily than larger ones. Skin moisture is another key factor affecting drug absorption. Higher level of moisture generally improve the absorption of substance especially those that are water soluble. Moistening occurs through water diffusion from adjacent layers or accumulation from topical applications or occlusive vehicles. Other factors that affect skin absorbed delivery include the application location and method, specific skin area, application time, skin age, and the use of carrier that alter the skin's barrier function. 

Transdermal Medication (5) 

Transdermal medications are used to treat and control a number of illnesses, including migraines, motion sickness, hypertension, and discomfort. This exercise will go over the transdermal drug's indications, modes of action, and contraindications, highlighting the fact that, when used appropriately, these drugs can be very successful forms of treatment. The mechanism of action, possible side effects, and other crucial elements  such as off-label applications, dosage, pharmacodynamics, pharmacokinetics, monitoring, and pertinent interactions will all be covered. The purpose of this information is to assist the interdisciplinary team in providing transdermal therapy to patients. 

Objectives: 

  • Explain the transdermal drug delivery mode of action and the different ways that can be done to improve penetration.
  • Summarize the potential risks associated with negative consequences of transdermal medications. 
  • Determine transdermal patch monitoring techniques 24 hours post-administration to identify any medicine delivery system or active ingredient toxicity. 
  • Describe the value of interprofessional collaboration in delivering patients with transdermal drug delivery techniques that result in high-quality care. Transdermal medications represents broad class of drugs designed to deliver active substances through the skin for either local or systemic effects via a specific formulation. This method of drug delivery has gained popularity owing to its substantial benefits. Transdermal medications, for example, circumvent the liver's first-pass metabolism, perhaps shielding it from harm. They also reduce the risk of gastrointestinal issues associated with oral administration, enhance patient adherence, and allow for steady, continuous drug delivery over time. The core principle behind transdermal drug delivery is the drug's ability to penetrate the skin and enter systemic circulation. However, only a limited number of drugs meet the necessary criteria to successfully overcome the barrier of the skin. Having a low molecular weight (less than 600 g/mol), being able to penetrate the skin, absorbing into blood vessels, and entering the bloodstream are some of these requirements. In addition, the active component needs to have sticky qualities, have a low daily dose for patient comfort, and maintain its chemical and physical stability. The medication should be able to be metabolized by the skin. As a result, there are relatively few successful transdermal medications that possess these specific characteristics.

 Since the 1970s , transdermal medications have been used to address various indications, including: 

?Hypertension

  • Angina pectoris
  • Pain management
  • Cessation of smoking
  • Migraines 
  • Major depression 
  • Parkinson's disease 
  • Alzheimer's disease ? ADHD 

When used as prescribed, transdermal administration has a long history of being safe and successful.

Mode Of Action (5)

The main obstacle to accomplishing successful transdermal drug delivery lies in getting active substances to diffuse through the skin's barrier, which consists of multiple layers. The outermost layer, known as the stratum corneum, is the thickest and is made up of many layers of corneocytes rich in keratin. Furthermore, when creating transdermal medications, two chemically unique sections of the stratum corneum must be taken into account. The keratin filaments have a lipid matrix positioned in between them and an aqueous layer at their outer surface. For transdermal drugs to function well, they must be able to diffuse through both of these regions. 

Recent advancements have been made in developing methods to enhance drug delivery through the transdermal route. These methods include (5): 

?Microneedles: These tiny, painless needles, it contains medication and might be solid or hollow, penetrate the stratum corneum without causing discomfort. This technique allows for the delivery of compounds with higher molecular weights. 

?Iontophoresis: This method uses an electrical driving force to move charged particles across the stratum corneum through electrophoresis. A continuous low current voltage promotes the dispersion of chemicals, with the delivery rate being managed by the patient or a microprocessor. 

?Thermal Infiltration: Heat therapy cause the skin to become permeable, which facilitates the easier passage of molecules through the stratum corneum. 

?Electropermeabilization: Using this method, a strong electrical voltage is applied to stratum corneum, creating tiny holes that allow molecules to diffuse. 

?Conventional Enhancers: These are substance that are used topically to change the active drug’s thermodynamics characteristics or to make the stratum corneum more permeable. 

?Sonography: Sound waves are used to break up the stratum corneum, which increases its permeability.

Administration (5) 

The administration of transdermal patches should begin with a thorough physical examination of the patient and consideration of any existing comorbidities. Here is a general overview of the steps for administering a transdermal patch: 

?Clean the Skin: Disinfect and clean the area of skin where the patch will be applied. 

?Apply the Patch: Position the patch where it is needed. 

?Follow-Up : Make an appointment for follow-up to monitor for any unfavorable skin response. 

?Adherence to Guidelines: For subsequent applications, be sure that the transdermal patch instruction are followed correctly. 

While the administration process may vary based on the specific medication delivered via the patch, for all transdermal patches, typically follow these instructions: 

  1. The patient should use clean water to clean and sanitize the application area, then pat it dry. When using the patch, they should abstain from using oils, lotions, soap, and alcohol. 
  2. Carefully remove the patch from its bag by opening it, peeling off both parts of the protective liner without touching the adhesive side. 
  3. Using the palm of your hand, firmly press the patch's sticky side against the skin. 
  4. Hold the patch in place for at least 30 seconds to ensure it adheres well, particularly around the periphery. 
  5. The borders of the patch can be secured using first-aid tape if it does not adhere well or comes away. If adhesion issues persist, see-through dressings may be applied, but other types of bandages or tapes should not cover the patch. 
  6. If a patch falls off before the scheduled removal time, It must be appropriately disposed of, and a fresh patch must be put while maintaining the same dosage interval. In such circumstances, patients should speak with their physician or pharmacist for advice. 
  7. After applying the patch, the patient should wash their hands with water immediately. 
  8. When it’s time to change the patch, the old patch should be removed and a new one applied to a distinct skin region. 
  9. The patch has to be properly disposed of after it has been removed by folding its sticky sides together. Patients should select different application sites to prevent skin irritation. Some patches are designed for shortterm wear (e.g., 12 hours), while others, like fentanyl patches, can be worn for up to 72 hours before needing to be replaced. Patients should be aware that a removed patch could still contain enough drug to be dangerous, particularly if kids might get to it. If a patch is ripped or broken, it should not be utilized since this may result in "dose dumping," which is the release of medicine in larger and faster amounts than recommended. Transdermal patch-related inquiries should be sent right away to the patient's physician or pharmacist. 

Unfavorable Impact (5) 

The main negative consequences associated with transdermal medication administration are skin responses. Transdermal patches are a popular way to apply active ingredients, but they can irritate the skin and cause symptoms like burning, itching, and redness in the vicinity. Reactions to allergens can also occur with all types of patches because of the active components that were utilized. Irritant contact dermatitis and allergic contact dermatitis are the two most commonly reported skin responses. These conditions are usually brought on by the medication, the patch, or ingredients such as adhesives and excipients. Furthermore, applying more than one patch when only one is required or leaving a patch on for longer than advised might lead to overdosing on medicine, which may result in an overdose. 

Contraindication (5) 

It is not advised for people with the following disorders to receive medication transdermally: 

  • Sensitivity to the transdermal patch’s active component 
  • Deficiency of essential fatty acid 
  • Dehydrated skin 
  • Dermatitis 
  • The Ichthyosis 
  • Dermatitis atopic 
  • Increasing UV radiation exposure 
  • Early born Babies 
  • Women who are expecting (depending on the particular medication being given).

Microfabricated Microneedle 

Microneedle technology denotes a remarkable advancement in controlled release technology. This innovative approach employs tiny needles, crafted from substances such as polysiloxane, metal, or glass, to penetrate the skin and create microscopic channels. These tiny channels help drugs pass through the top layer of the skin and enter deeper tissues. There, they are absorbed into the bloodstream for delivery throughout the body (6). One of the biggest advantages of microneedle technique is its ability to solve the problems that come with traditional skin patch drug delivery.. The skin's natural protection role often hinders the absorption of drugs applied topically. Microneedles, however, can effectively penetrate this barrier, enabling the efficient and successful transport of complex molecules, including proteins, vaccines, and peptides. This breakthrough has opened up new possibilities for drug administration, particularly for patients who struggle with swallowing or require alternative methods (7). Microneedle technology can be customized to fit the specific needs of different medicines and patients. The size, shape, and contents of microneedles can be changed to improve drug delivery for various purposes. Microneedles can also be covered with drugs or used to carry medicines through tiny channels, making them even more useful. These improvements have led to the use of microneedles in delivering drugs and vaccines, cosmetics, and diagnosing diseases (8). Microneedle technology can employ a single microneedle, a row of microneedles, or a whole array of microneedles with precise dimensions. Depending on the production method, microneedles can be shaped as cones or square pyramids. These variations allow for flexibility in design and application (9). Extraneous factors like skin problems, the type of drug, and weather can affect how well microneedles deliver drugs. Humidity and temperature can change how quickly the drug is released, with dry conditions slowing it down and wet conditions interfering. Too much sweat can stop the patch from sticking to the skin, which can prevent the drug from being delivered. The pH of the skin also plays a role, with extreme pH levels reducing drug absorption. Skin lipids can create a barrier, but removing them can improve drug absorption. Raising skin temperature can enhance drug delivery by increasing diffusion and dilating blood vessels (10). One of the significant merits of microneedle technology is the potential for lower dosages compared to oral ingestion. By bypassing the digestive system and first-pass metabolism, microneedles can reduce the amount of drug that is lost before reaching the bloodstream, allowing for more efficient and effective drug delivery. This can lead to improved therapeutic outcomes and potentially fewer side effects (11).

Element Of Microneedles

The composition and constituents of the patch determine the type of material used to make microneedles, which can range from metal to polymer. The strength of these substances needs to be sufficient to pierce flesh. Nondissolving materials are used to create inert, nontoxic, and powerful enough microneedles that can pierce skin without triggering an immune reaction. But coated or dissolving materials-based microneedles need to be biocompatible and dissolve in water. In the body, they need to likewise breakdown or disintegrate without harming someone. During production, storage, and delivery, it is critical that the materials used to make microneedles are compatible with the medications they contain. The characteristics of the various materials used to create microneedles are described (12).

Silicon: Silicon and materials derived from it are robust, stable, and simple to work with. These materials are commonly used in microneedle-based drug delivery systems. However, silicon may have negative effects on the body and microneedles made of silicon are brittle when placed into the skin. Researchers have attempted to coat silicon microneedles in gold or optimize their etching process in order to increase their mechanical strength and biocompatibility. Researchers have developed thin, tapered silicon microneedles that are simpler to implant into the skin without breaking by refining the etching process. Furthermore, the hardness of silicon microneedles can be increased by refining their size and structure. Silicon microneedles typically have a length of 150–1700 micrometers with a needle pitch of 260–2000 micrometers (13).

Metal: Numerous metals and their alloys, including stainless steel, titanium, palladium, nickel, tungsten, gold, and silver, have been used to create microneedles due to their strength and durability. Compared to glass and silicon microneedles, metallic microneedles are easier to make and less expensive. Two common methods for fabricating metallic microneedles are laser cutting and electrode position. Stainless steel and titanium are popular choices for metallic microneedles because they are safe for the body and strong. However, these metals can corrode and cause allergic reactions over time. To avoid these problems, microneedles made from these metals are often coated with other materials. Palladium and nickel are used to create hollow metallic microneedles through a process called electrode position. Palladium is safe for the body, but nickel can cause skin irritation or toxicity. To prevent this, nickel-based microneedles are often coated with a layer of biocompatible material. Silver and gold are also used as coatings on microneedles to improve their compatibility or for antibacterial or biosensor purposes. Recently, researchers have developed a new method for fabricating metallic microneedles using thermoplastic drawing of metallic glasses. This method is simpler and more convenient than traditional methods (14).

Polymer: Polymer microneedles present a viable substitute for conventional medication delivery techniques. Polymers are typically more affordable, biocompatible, and biodegradable than metal or silicon. Additional advantages for medication delivery come from their capacity to expand or dissolve in the body. Although polymers can be less strong than other materials, scientists are looking into ways to strengthen them mechanically by combining and adding other components. The design of the microneedle, the manufacturing method, and the polymer selection all provide a significant role in how effective polymer microneedles are. A vast variety of medications, from tiny compounds to macromolecules like biotherapeutics, can be delivered using polymers. When compared to typical injections, microneedles provide a more comfortable and efficient means of administering medication, particularly for biotherapeutics that are challenging to administer via other means (15).Microneedles have been produced from a diverse range of polymers, including “polylactideco-glycolide acid (PLGA), poly-L-lactic acid (PLA), polycaprolactone (PCL), poly-glycolic acid (PGA), fibroin, sodium alginate, chitosan, polyvinyl alcohol (PVA), hyaluronic acids (HA), polyvinyl pyrrolidone (PVP), polyvinyl alcohol (PVA), carboxymethyl cellulose (CMC), and others.”(16).

Ceramic: Micro molding, a technique that involves pouring ceramic slurry into tiny molds, is used to create ceramic microneedles. For large-scale production, this approach works well because it is scalable and inexpensive. For microneedles, alumina is the most widely utilized ceramic substance. In tension, alumina is brittle but strong under compression. It is applicable to medication delivery by drug-coated microneedle arrays. For microneedles, other biocompatible ceramics with strong mechanical qualities, such as calcium phosphate dehydrate and calcium sulfate dihydrate, can be utilized. Microneedle fabrication can also be done with Ormocer®, an organic-ceramic hybrid material. Its composition consists of silicon alkoxides and organic monomers, forming a three-dimensional network (17).

Glass: Glass microneedles are tiny needles made from glass. They are cheap, safe for the body, easy to sterilize, and can be made in various shapes. Glass microneedles are transparent, which allows for easy visualization of fluid flow. They can be used for dermal interstitial fluid extraction and intradermal insulin infusion. However, glass microneedles are difficult to produce using chemical methods and can be brittle. Borosilicate glass is a type of glass often used for microneedles. It is biocompatible and has been used in cortical implants. However, silica glass may cause granulomas in the skin. For pharmaceutical applications, borosilicate glass is generally preferred over silica glass (18).

Types Of Microneedle

Microneedle transdermal systems are a contemporary drug delivery technique that penetrates the skin using minuscule, needle-like devices. Microneedle systems can be categorized as solid, hollow, coated, dissolvable/dissolving, or hydrogel forming, depending on their composition and intended use. For the purpose of administering medications in a regulated and focused way, each kind has special benefits.

  1. Solid Microneedle  

Solid microneedles are typically easier to manufacture, have superior mechanical properties, and offer sharper points, allowing for more efficient penetration of the skin barrier. These needles are designed to create microscopic channels in the skin, allowing for more efficient drug absorption into the deeper layers. Compared to hollow microneedles, solid microneedles are generally easier to manufacture, possess superior mechanical properties, and offer sharper tips, making them more effective in penetrating the skin barrier. Moreover, they can be fabricated from a wider range of materials, including silicon, metals, and polymers, providing versatility in their design and application. (10) (18). While solid microneedles offer several advantages, it's important to consider their potential limitations. One key challenge is maintaining prolonged drug release, as the skin's natural repair mechanisms can lead to the closure of the microscopic channels created by the needles. This can limit the duration of drug exposure and reduce the overall therapeutic efficacy. To address this issue, researchers are exploring strategies to prolong the permeability of the skin barrier and enhance the sustained release of drugs from solid microneedle systems. (19).

Hollow Microneedle 

Hollow microneedles inject liquids through the skin. Hollow microneedles offer the benefit of larger drug doses and providing more precise control over drug administration, hollow microneedles are generally more complex to manufacture and mechanically weaker than solid microneedles, making them more susceptible to breakage or deformation. New advancements in microneedle technology have led to focus on addressing the limitations of hollow microneedles. Researchers have developed innovative designs, such as out-of-plane hollow microneedles, to mitigate clogging issues and improve drug delivery efficiency. Additionally, micromachining techniques have been working to constructed hollow microneedles with greater precision and consistency (20).Hollow microneedles can be constructed from a range of materials including ceramics, metals, silicon, and glass. Each needle typically contains a hollow space and a passage at the tip, allowing to deliver small volumes of drugs dermally. This design enables hollow microneedles to deliver higher drug payloads compared to solid, coated, or dissolving microneedle arrays (21).

Coated Microneedle

Coated microneedles are a type of method that employ solid needles cover in drug solution. Coated microneedle generally carry a smaller quantity of medication compare to other microneedle type , depending on the coating layer thickness. The effectiveness of coated microneedle relies on the ability to consistently apply a control medication layer onto the needle. These microneedles are particularly effective for delivering large molecules like “proteins and DNA” into the skin in a least invasive method (10). They offer a convenient, bandage-like application and can enhance drug stability, even at room temperature. Coated microneedles are also well-suited for delivering vaccines to the skin, as they can release antigens in the skin to target specific immune cells, leading to a stronger immune response (22). Coated microneedles can be made using different coating methods. Spray coating is one method, but it wastes a lot of drug. Inkjet printing is another method that is more precise but takes a long time for large patches. Dip coating is the most common method, but it has limitations in drug loading and large-scale production. Overall, precise drug dosing, consistent drug content, and efficient large-scale production remain challenges in the manufacturing of coated microneedles (23).

Dissolving Microneedle

Dissolving microneedles are a specialized method of drug delivery where needles made from biodegradable polymers are used. These microneedles dissolve when inserted into the skin., releasing the embedded drug payload straight intothe dermal tissue. This method providesa minimally Less invasive alternative to conventional injections, eliminating the associated pain and risk of infection (24). Dissolving microneedles can be fabricated using different water-soluble polymers, including polyvinylpyrrolidone (PVP), hyaluronic acid (HA), maltose, dextran, albumin, and chondroitin sulfate. The desired drug can be includedinto the polymer matrix during the manufacturing process, ensuring its controlled release upon dissolution. This allows for the targeted delivery of both small molecules and macromolecules, such as DNA and proteins, to the skin. Micromolding is a commonly employed technique for the fabrication of dissolving microneedles. This method involves the use of molds to shape the polymer material into the desired needle configuration (25).

Hydrogel Forming Microneedle

Hydrogel-forming microneedle belong to the category of drug delivery systemstiny, needle-like structures to penetrate the skin andand promote the delivery of therapeutic agents. These microneedles are composed of crosslinked polymers that absorb water and swell upon insertion into the skin, forming temporary conduits for drug diffusion. While Hydrogen-forming microneedle offer several advantages, including controlled drug release, improved skin absorption, and minimal invasiveness, they are primarily designed for the delivery of hydrophilic molecules. Hydrophobic drugs, which are often characterized by their low solubility in aqueous environments, present significant challenges for delivery via Hydrogen-forming microneedle. To overcome these challenges, various strategies have been explored, including the incorporation of solubilizing excipients and the modification of the hydrogel matrix to enhance its affinity for hydrophobic molecules. One promising approach is the use of solid dispersion (SD) techniques. SD involves dispersing hydrophobic drugs within hydrophilic carriers, increasing their surface area and promoting dissolution in aqueous environments. Commonly used hydrophilic carriers for SD include polyvinylpyrrolidone (PVP), polyethylene glycols (PEG), and polymethacrylates. These carriers possess favorable properties, such as biocompatibility, low melting points, and established safety profiles, making them suitable for use in drug delivery systems (26).

Fabrication Technique

Microneedle drug delivery systems can be fabricated utilizing multiple approaches, including microelectromechanical systems (MEMS), micromolding, laser ablation, laser cutting, droplet-born air blowing, pulling pipettes, and atomized spraying.

Microelectromechanical System (MEMS) (27)

Micro/nanostructures (MNs) are fabricated using a three-step process involving deposition, patterning, and etching.

Deposition

Deposition is the initial step in the fabrication process where a thin film is created on a substrate. This can be done using either chemical vapor deposition (CVD) or physical vapor deposition (PVD). In CVD, a chemical reaction on the substrate surface forms the film. In PVD, atoms are transferred directly from a source to the substrate through the gas phase.

Patterning

Patterning is a crucial step in the fabrication process where a desired pattern is transferred onto a photosensitivecoated substrate. This is typically achieved using lithography, such as photolithography, ion beam lithography, or X-ray lithography. Photolithography is a particularly important technique in this process. It involves exposing a substrate coated with a photoresist to UV light through a mask. The exposed photoresist undergoes a chemical reaction, making it either more or less soluble in a developer. This allows for the selective removal of the photoresist, leaving behind the desired pattern. Molds for microneedles can also be created using a similar process. A rigid silicone mold is first made with the desired pattern. Then, a negative mold is created using polydimethylsiloxane (PDMS). This negative mold can be used to replicate the pattern onto other materials.

Etching

Etching is the final step in the manufacturing process where unwanted material is removed to create the desired pattern or structure. Wet and dry are the primary types of etching. Wet etching involves immersing the reactant in a liquid chemical to remove unwanted material. Etching can be uniform in all directions (isotropic) or uneven (anisotropic).Dry etching employs a vapor phase or plasma etcher to remove material. Reactive ion etching (RIE) and ion-beam milling (IBM) are two common types of dry etching.RIE uses a reactive gas that interacts with the substrate to remove material. The level of uniformity can be controlled by adjusting the gas pressure and electric field. IBM physically removes material by bombarding it with inert ions. Although RIE can fabricate structures, it etches slowly and struggles to maintain a tall, narrow profile. Deep reactive ion etching (DRIE), or the Bosch process, is a specialized technique used for creating hollow microneedles with deep structures. Combining wet and dry etching techniques can often produce the best results, especially for creating well-defined and sharp microneedle tips.

Micromolding

Micromolding is a versatile technique used to fabricate microneedles, which are tiny needles designed for diverse uses, such as medication administration and diagnosis. This method involves creating a negative mold with cavities that correspond to the desired shape of the microneedles. The Matrix is then filled with an appropriate substance, which is subsequently hardened to form the completed microneedles. Micromolding offers several advantages. It is a straightforward, affordable, and highly repeatable process, making it suitable for large-scale production. Additionally, micromolding allows for the utilisation of a vast array of substances, encompassing "organic and artificial polymers, ceramics, hydrogels, and more". This versatility enables the creation of microneedles with diverse properties and functionalities. Furthermore, micromolding can be used to produce intricate microneedle configurations, such as multiregional, core-shell, stacked, swelling, and suction cup designs. These structures can have intricate release kinetics and functions, making them suitable for specific applications. For instance, multiregional microneedles can deliver different drugs to distinct layers of the skin, while swelling microneedles can expand upon insertion to increase drug delivery efficiency. However, micromolding also has limitations. One of the primary challenges is mold-filling. Surface tension can make it challenging to fill materials into microscale molds against gravity. Various techniques, such as vacuum, centrifugation, imprinting, spinning coating, atomized spray, and infiltration, have been developed to address this issue. Micromolding faces challenges in fabricating complex adhesive structures with barbs and hollow features. Moreover, Unmolding stress can impair the resulting microneedles, especially when working with delicate and brittle materials like hydrogel. Managing the extent of insertion, medication content, and physical properties of the polymer are also obstacles that require to be addressed Ultimately, micromolding is inappropriate for manufacturing materials such as metal, silicon, and glass. Despite these limitations, micromolding remains a valuable technique for manufacturing microneedles. Its simplicity, versatility, and reproducibility make it a popular choice for researchers and industries seeking to develop innovative microneedle-based technologies (28).

Laser Ablation

First, a mold insert is created using laser machining, where a femtosecond laser is employed to ablate the desired cavities. The laser parameters, such as wavelength, pulse repetition rate, and pulse energy, are optimized to ensure efficient material removal. A cross-hatching scanning strategy is used to form circular cavities with precise dimensions. Subsequently, the mold insert is employed in an injection molding process to duplicate the microneedle  structure. The injection molding parameters, including mold temperature, injection temperature, injection rate, and holding pressure, are carefully adjusted to achieve high-quality microneedles. To characterize the fabricated microneedles, both the ablated cavities in the mold insert and the replicated structures in the injection-molded parts are analyzed using micro-CT and digital microscopy, respectively. This allows for the evaluation of the geometry and quality of the microneedles (29).

Laser Cutting

The initial stage of the technique entails fabricating a microneedle matrix utilizing a CO2 laser cutter. A polymethylmethacrylate (PMMA) sheet serves as the substrate, and the laser is used to engrave the desired microneedle patterns. By carefully controlling the laser power, speed, and scanning parameters, it is possible to achieve precise control over the depth and shape of the engraved grooves. To ensure accurate dimensions and consistent cone formation of the microneedles, the engraving process is monitored in real-time using a camera integrated into the laser cutter. The dimensions are further verified using a high-resolution 3D digital panoramic microscope. Once the microneedle mold is fabricated, the next step is to prepare the polymeric solutions that will be used to create the microneedle .A variety of hydrophilic materials, including gelatin, kollicoat IR, polyvinyl alcohol, and poloxamer 338, are dispersed in distilled water and warmed to ensure complete dissolution A variety of hydrophilic materials, including gelatin, kollicoat IR, polyvinyl alcohol, and poloxamer 338, are dissolved in distilled water and heated to ensure complete dissolution. The selected model drugs, are then incorporated into the polymeric solutions. The resulting mixtures are carefully stirred to ensure homogeneity and prevent phase separation. The medicated solutions are then poured into the microneedle matrix and allowed to dehydrated in a vacuum oven .During the drying process, the solutions infiltrate the engraved grooves, forming the microneedle structures. After drying, the microneedle patches are gently detached from matrix  and stored in a Desiccation cabinet under phosphorous pentoxide to maintain a low humidity environment. This storage condition helps to prevent degradation of the patches and ensure their stability over time (30).

Droplet-Born Air Blowing Method 

This novel technique presents a distinctive method of producing polymeric microneedles without the necessity for traditional silicon mold. Through the use of air blowing, polymer droplets are converted into microneedle structures, 'offering a delicate' fabrication 'procedure that eschews severe conditions like UV irradiation or heat. In the droplet-born air blowing technique, polymer solution drops are organized in a grid pattern on two plates. These plates are then joined together and moved at a regulated speed. When the plates reach their maximum distance, - the extended polymer is solidified using air blowing, resulting in the formation of microneedles. The recent inclusion of 'a cyclic contact and drying procedure' (CCDP process) has further improved this method, permitting the production of dissolvable microneedle patches. These patches offer the advantage of simple microneedle  separation from the backing film. One of the principal advantages of this approach is the capability to accurately regulate droplet dimensions and concentration, enabling controlled medication loading without any drug wastage. The entire procedure generally takes approximately 10 minutes and has been effectively applied to produce drug-loaded microneedles (31).

Pulling Pipettes

In this method, microneedles fabricated using a micropipette puller and beveler. The microneedles were made from fire-polished borosilicate glass pipettes and were cleaned using chromic acid, followed by water and acetone rinses. The microneedle geometries were characterized using bright-field microscopy and image analysis. The effective tip opening radius was determined to be between 22 and 48 µm, with a tip bevel angle of 35 to 38 degrees. The oval shape of the tip opening was considered when calculating the effective radius (32,33).

Atomized Spraying Method

The atomised spray-filling method addresses the limitations associated with large-scale manufacturing of dissolving microneedles with desired shape and physical properties. It also reduces the difficulties presented by interfacial tension and thickness during matrix filling. Dissolving microneedles can be produced from a variety of materials, including sugars (fructose, and raffinose) and polymers (PVA, PVP, CMC, HPMC, and sodium alginate).The procedure involves connecting a orifice to an air vent and a fluid prepration generating an atomized mist.. The spray is then directed onto the PDMS mold, and the solution is allowed to dry. The atomised sprayfilling method can also be used to fabricate layered microneedles. By controlling the spraying parameters and the deposition of multiple layers, it is possible to create microneedles with distinct structures and properties (34).

ADVANTAGES

  • Microneedles are a promising Medication administration method that Provides several key Benefits (35 , 36) :
  • Microneedles are minimally invasive, causing minimal pain and discomfort.
  • Microneedles prevent infection and minimize tissue injury.
  • Microneedles enable targeted drug delivery directly to the epidermis.
  • Microneedles bypass the first-pass effect, facilitating improved drug targeting and bioavailability.
  • Microneedles enhance drug absorption by generating microscopic channels in the skin, allowing for more             efficient drug entry and transport into the bloodstream.
  • Microneedles are user-friendly, offering patients a convenient option. They are often self-administered and require minimal preparation.
  • Microneedles are suitable for both self-medication and the administration of drugs to unconscious patients.
  • Microneedles offer therapeutic benefits, including faster onset of action, higher drug levels in the bloodstream, and enhanced healing.
  • Microneedles can deliver a variety of substances, from small molecules to large biological compounds.. This versatility makes them suitable for various therapeutic applications.
  • Microneedles enhance patient satisfaction by significantly reducing pain and discomfort during drug administration.
  • Microneedles provide a non-invasive alternative to traditional needles, as they cause minimal distress and uneasiness and reduce the Potential for infection and tissue damage.
  • Microneedles offer the potential for lower dosages compared to oral administration, which can be beneficial in certain cases.
  • Microneedles can be constructed to deliver medications at a controlled rate, ensuring Prolonged therapeutic levels and reducing the need for frequent dosing.
  • Microneedles are less likely to allow bacteria or other microorganisms to enter the body compared to hypodermic needles, due to their limited skin penetration.
  • Microneedles are generally well-tolerated, with minimal long-term edema or erythema.

DISADVANTAGES

Microneedles, while offering several advantages, also have some potential disadvantages (37) :

  • Microneedles might have slightly less precise dosage control compared to hypodermic needles. 
  • Careful handling is essential to prevent drug loss and ensure consistent penetration depth. 
  • Individual skin variations, such as the Depth of the horny layer, can influence drug delivery. 
  • External factors like skin hydration can affect drug absorption. 
  • Repetitive injections may lead to vein collapse.
  • The microneedle tip may fracture and become lodged in the skin after patch removal.
  • A microdose of the drug, less than 1 mg, can be administered as a single injection.
  • Thickened skin can block the insertion of hollow microneedles.
  • Microneedles can be difficult to develop and manufacture, particularly for certain medication formulations or uses.
  • In some situations, Microneedles may induce skin redness, itching, or swelling, particularly in people with delicate skin.

Applications

Microneedles have developed as a useful tool for a variety of medicinal applications, with substantial benefits over previous approaches. Here's an overview of their main applications (13 , 38 , 39):

  • Microneedle-based vaccine administration

Microneedles are a Favorable vaccine administration method that offers several advantages over traditional injections.They provide a less invasive approach, stimulate a stronger immune response, reduce needle phobia, and facilitate efficient mass vaccination campaigns.

  • Insulin administration using microneedles

Microneedle-based insulin delivery offers improved glycemic control, a less invasive alternative to injections, and ensures proper biological effects.

  • Utilizing microneedles to administer parathyroid hormone

Microneedle-based parathyroid hormone delivery offers a targeted approach for localized treatment and has Revealed favorable results in clinical trials for Enhancing bone health.

  • Microneedles for Anesthetic Delivery

Microneedle-based anesthetic delivery, such as lidocaine offers a more comfortable and effective alternative to traditional injections, reducing pain and improving the overall patient experience.

  • Microneedles for Cosmetic Purposes

Microneedle-based cosmetic procedures Promote collagen growth, refine skin texture, and minimize wrinkles and acne scars, and offer a minimally invasive approach to skin rejuvenation.

  • Microneedles for Naltrexone Delivery  

Microneedle patches have shown potential for treating opioid dependence and alcohol addiction.By delivering naltrexone, a medication that blocks the effects of opioids, microneedles can help individuals overcome addiction.

  • Microneedle for Disease Diagnosis and Monitoring

Microneedle-based disease diagnosis and monitoring systems offer continuous glucose monitoring for diabetes, detect biomarkers for various diseases, and extract interstitial fluid for analysis.

  • Microneedle patch for iron supplementation in anemia

Microneedle patches loaded with ferric pyrophosphate can effectively treat iron deficiency anemia by delivering iron directly through the skin.

  • Microneedles for percutaneous protein delivery

Microneedle masks fabricated using CLIP techniques can deliver proteins such as serum albumin and ovalbumin, offering a non-invasive approach for protein therapy.

  • Microneedles for subcutaneous tumor 

Microneedle patches containing sodium hyaluronate and 5-aminolevulinic acid can be used to treat subcutaneous tumors through photodynamic therapy.

  • Microneedle Biosensors for Continuous Monitoring

Microneedle biosensors are emerging as a valuable tool for continuous monitoring of various biomarkers. These innovative devices integrate sensing elements into microneedles, allowing for non-invasive and realtime measurement of glucose, lactate, alcohol, beta-lactam, and other substances. By providing continuous data, microneedle biosensors can aid in disease diagnosis, health monitoring, and treatment management. 

  • Microneedles for Fluid Extraction, Nerve Stimulation, and Recording

Microneedles have proven to be valuable tools for various medical procedures beyond drug delivery. They can be used for fluid extraction, nerve stimulation, and recording, offering innovative solutions for healthcare. For fluid extraction, microneedle patches, hydrogel microneedles, and paper-based methods can effectively collect interstitial fluid, a valuable source of biomarkers for health monitoring. In  nerve stimulation, microneedle electrodes can be used for transcutaneous electrical nerve stimulation (TENS) to manage pain. Additionally, microneedle sensor arrays can detect opioid drugs and organophosphate nerve agents, enabling rapid human body induction. For electrophysiological recordings, microneedle electrodes can be used to record electrical signals from the nervous system, providing insights into neural activity.

  • Microneedles for Cancer Therapy

Microneedles are emerging as a promising technology for cancer therapy, offering efficient delivery of various therapeutic agents. By directly delivering anticancer drugs, proteins, and vaccines to tumor sites, microneedles can enhance bioavailability, reduce side effects, and enable targeted treatment. This minimally invasive approach holds great potential for improving outcomes in cancer patients, especially when combined with other therapies.

  • Microneedles for ophthalmic drug delivery

Microneedles provide a more comfortable alternative to intravitreal injections for ocular drug delivery, offering the likelihood of improved outcomes and fewer adverse reactions.

Overview On Microneedle

Research Article on Microneedle Patches:

 

Sr.

No.

Drug

Method

Citation

1.

Valsartan

------

(40)

2.

Carvedilol

------

(41)

3.

Lornoxicam

------

(42)

4.

Insulin

------

(43)

5.

Butorphanol tartrate

Solvent casting method

(44)

6.

Insulin

Solvent casting method

(45)

7.

Amphotericin B

Probe sonication

(46)

8.

Lidocaine

Centrifugal lithography

(47)

9.

Amphotericin B

Solvent casting

(48)

10.

Insulin

Solvent casting

(49)

11.

Vitamin B12

Solvent casting

(50)

12.

Gentamicin

Solvent evaporation

(51)

13.

Dihydro- ergotamine mesylate

Solvent casting

(52)

14.

Influenza virus

------

(53)

15.

Protein, Peptide and Antibody

------

(54)

16.

Sodium nitroprusside and sodium thiosulfate

Centrifugation casting method

(55)

17.

Ibuprofen sodium

Centrifugation casting method

(56)

18.

Losartan potassium

Film formation

(57)

19.

Amlodipine besylate

-------

(58)

20.

Ferric pyrophosphate (FPP)

Mold casting method

(24)

21.

Meloxicam

------

(59)

22.

Simvastatin

Solvent casting method.

(60)

23.

Propranolol hydrochloride

Casting method

(25)

24.

Etravirine

Solvent Evaporation-Antisolvent

Precipitation Method

(61)

25.

Hyaluronic acid

------

(62)

26.

Peptide, Collagen

------

(63)

27.

Niacinamide

------

(64)

28.

Hyaluronic Acid serum

------

(65)

29.

Salicylic Acid, Hyaluronic Acid, Epiallocaine Gallet.

 

(66)

30.

Collagen

------

(67)

31.

Sodium Hyluronate –90% Peptide – 2% Vitamin E – 2% Collagen – 4%

------

(68)

32.

Calcipotriol, Betamethasone dipropionate.

-------

(69)

33.

Adenosine

-------

(70)

34.

Tacrolimus

-------

(71)

35.

Doxazosin mesylate

 

-------

(72)

36.

Itraconazole

-------

(73)

37.

Progesterone

-------

(74)

38.

Ibuprofen sodium

-------

(75)

39.   

 Primaquine

------

(76)

40.

Sodium nitroprusside and sodium thiosulfate.

Centrifugation casting method.

(77)

41.

Recombinant human growth hormone

-------

(78)

42.

Acyclovir

Laser-engineered

(79)

43.

Besifloxacin

Micromolding

(80)

44.

Meloxicam

-------

(81)

45.

Ferrous sulfate nanoparticles

(FS NPs)

-------

 

(82)

46.

Minoxidil

-------

(83)

47.

Amoxicillin Sodium

-------

(84)

48.

Levodopa and Carbidopa

Two-layer dissolving MAP casting.

(85)

49.

Nimodipine

-------

(86)

50.

Olanzapine

Nano-precipitation method - casting method

(87)

Marketed Microneedle Patches:

 

Sr.

No.

Drug

Manufacturer

Product

Name

Indication

Citation

1.

Zolmitriptan

Zosano pharma

Qtrypta

Migraine treatment, Cluster headache treatment

(88)

2.

Salicylic Acid

The derma co

Micro tip

Salicylic Acid

Acne treatment, hyperpigmentation, psoriasis, callus removal, skin rejuvenation

(89)

3.

Teriparatide acetate

Nemaura Pharma

Teriparatide micro patch

Osteoporosis treatment, osteopenia treatment

(90)

4.

Influenza vaccine

Sanofi Pasteur

Intanza

Seasonal influenza prevention, pandemic influenza preparedness

(91)

5.

Hyaluronic acid

Dermatude

Microneedle patch

Hydration, anti-aging, wound healing, skin rejuvenation, acne treatment

(65)

6.

Antibodies

Vaxxas

Microneedle patch for antibodies

Infectious diseases, autoimmune diseases, cancer treatment, neurological disorders

(92)

7.

Peptides

Neutrogena

Rapid wrinkle repair microneedle patch

Anti-aging, skin rejuvenation, hair growth promotion, acne treatment, pain management, wound healing, inflammation reduction

(93)

8.

Proteins

Bioactive

Protein microneedle patch

Anti-aging, skin rejuvenation

(94)

9.

Collagen

Dermatude

Microneedle patch

Anti-aging, skin rejuvenation, hair growth promotion, acne treatment, pain management, wound healing, inflammation reduction Wound healing, burn care

(95)

10.

Glutathione

MDPI

Microneedle patch for skin whitening

Skin rejuvenation, wrinkle reduction, hyperpigmentation, skin brightening, detoxification

(96)

11.

Niacinamide

Dermatude

Mesopure microneedle patch

Anti-aging, skin brightening, hydration, acne treatment, skin elasticity improvement, hyperpigmentation, rosacea treatment

(97)

12.

Sodium

Hyaluronate

Lumen

Sodium

Hyaluronate 3% microneedle patch

Facial rejuvenation, lip augmentation, skin tightening, scar treatment, burn care, hydration, anti-aging

(98)

13.

Tranexamic acid

Skin republic

Tranexamic acid micro- needle patch

Hyperpigmentation, acne treatment, scar treatment, facial rejuvenation, skin brightening

(99)

14.

Glycyrrhiza

Glabra

Dr. CYJ

Glycyrrhiza Glabra microneedle patch

Anti-inflammatory, anti-aging, hydration, skin brightening, wound healing, eczema, dermatitis treatment

(100)

15.

Niacinamide

Avareele

Microneedle patch

Multi Dart spot leach microneedle patch

(64)

16.

Hyaluronic Acid serum

China Pvt. Ltd.

Microneedle eye patch

Hyaluronic Acid microneedle eyepatch

(65)

17.

Salicylic Acid,

Hyaluronic Acid,

Epiallocaine Gallet.

BBOLD

Dissolvable Microneedle acne patch

Unique formulation to fight acne from the inside.

(66)

18.

Collagen

GharSaapos + Ayurved Science

Skin microneedle infusion system

Stimulates collagen whilst infusing active ingredients into skin.

(67)

19.

Sodium

Hyluronate – 90%

Peptide – 2%

Vitamin E – 2%

Collagen – 4%

Frownie Patches

Dissolvable forehead microneedle patches

Brighten dry and dull skin.

(68)

20.

Calcipotriol,

Betamethasone dipropionate.

Nissna Co. Ltd.

Microneedle patch

Dissolving microneedle patches for cosmetics

(69)

Patented Microneedle Patch:

 

Sr.

No.

Drug

Patent No.

Country

Date

Citation

1.

Colchicine

CN113133991B

China

2023-06-13

(101)

2.

Fluconazole and doxycycline

CN116270666A

China

2023-06-23

(102)

3.

Liraglutide

CN116350751A

China

2023-06-30

(103)

4.

Timolol maleate

CN116421874A

China

2023-07-14

(104)

5.

1) Vitamin C or derivatives 2) Glutathione 3) Tocopherol or derivatives 4) Alpha lipoic acid.

KR102563820B1

Korea

2023-08-07

(105)

6.

Itraconazole

CN116617150A

China

2023-08-22

(106)

7.

Taxol

CN116687833A

China

2023-09-05

(107)

8.

Hyaluronic acid

CN116725939A

China

2023-09-12

(108)

9.

Paeonol

CN116763715A

China

2023-09-19

(109)

10.

Levosimendan

CN116440062B

China

2023-09-26

(110)

11.

Interferon

US20230330010A1

US

2023-10-19

(111)

12.

Ginsenoside Rg3

CN116763716A

China

2023-10 -24

(112)

13.

Progesterone lipsosome

CN117018422A

China

2023-11-10

(113)

14.

Sparfloxacin and manganese based nano drug

CN117258131A

China

2023-12-22

(114)

15.

Levothyroxine sodium

CN117503682A

China

2024-02-06

(115)

16.

Dutasteride

CN117598988A

China

2024-02-27

(116)

17.

Metformin

KR20240117782A

Korea

2024-08-02

(117)

18.

Lidocaine

Hydrochloride,

CN118615229A

China

2024-09-10

(118)

19.

Minoxidil

WO2024187056A2

US

2024-09-12

(119)

20.

Oligonucleotide

WO2024186627A1

US

2024-09-12

(120)

CONCLUSION 

Microneedles provide an highly efficient approach, to absorbing medication. They represent an advancement in drug delivery systems (TDDS). Constructed from materials, like silicon s, metal, polymers, glass and ceramics. These tiny synthetic devices form microchannels in the skin to aid in the absorption of drugs without penetrating. Microneedles come in various types, including solid, coated, hollow, and dissolvable, each offering distinct advantages depending on the desired treatment and drug properties. Various methods have been developed to create microneedles such, as Microelectromechanical Systems (MEMS) Micromolding techniques like Laser Ablation and Laser Cutting. Atomized Spraying Method and Droplet Born Air Blowing method are utilized along, with Pulling Pipettes in the fabrication process.Despite their constraints, in administering medication and the possibility of causing irritation microneedles have a diverse array of uses. As research progresses further into the field of fabrication techniques and the development of structures become more dynamic, in nature; they play a role, in enhancing the healthcare system. After examining 50 research papers on patches it is evident that there have been strides, in enhancing the delivery of drugs through the skin, for better release efficacy. The commercial bioavailability of the microneedle patch is showcased through the development of 20 marketed products and 20 patented works. Therefore the future prospects of microneedle patches, in healthcare seem thanks to research and advancements, in fabrication techniques that enhance their capabilities.

REFERENCES

        1. Singhal, P., , Singhal, R., Kumar, V., Goel, K. K., Jangra, A. K., & Yadav, R. (2012). Transdermal Drug Delivery System: A Novel Technique To Enhance Therapeutic Efficacy And Safety Of Drugs [Review Article]. American Journal of PharmTech Research, 106–107. http://www.ajptr.com/ (Original work published 2012)
        2. Tanwar, H., & Sachdeva, R. (2016). Transdermal Drug Delivery System: A Review. International Journal of Pharmaceutical Sciences and Research, 7(6). https://doi.org/10.13040/ijpsr.09758232.7(6).2274-90
        3. Yousef, H., Alhajj, M., Fakoya, A. O., & Sharma, S. (2024, June 8). Anatomy, Skin (Integument), Epidermis. StatPearls - NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK470464/
        4. Yu, Y., Yang, X., Wu, X., & Fan, Y. (2021). Enhancing Permeation of Drug Molecules Across the Skin via Delivery in Nanocarriers: Novel Strategies for Effective Transdermal Applications. Frontiers in Bioengineering and Biotechnology, 9. https://doi.org/10.3389/fbioe.2021.646554.
        5. Khan, S., & Sharman, T. (2023, February 6). Transdermal Medications. StatPearls - NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK556035/
        6. Golhar, A.  (2020). Introduction   to Novel Drug Delivery System. Unipune. https://www.academia.edu/43564084/Introduction_to_Novel_Drug_Delivery_System
        7. Halder, J., Gupta, S., Kumari, R., Gupta, G. D., & Rai, V. K. (2020). Microneedle Array: Applications, Recent Advances, and Clinical Pertinence in Transdermal Drug Delivery. Journal of Pharmaceutical Innovation, 16(3), 558–565. https://doi.org/10.1007/s12247-020-09460-2
        8. Dharadhar, S., Majumdar, A. S., Bombay College of Pharmacy, Dhoble, S., Institute of Chemical Technology, Mumbai, Patravale, V., & Institute of Chemical Technology, Mumbai. (2018). Microneedles for Transdermal Drug Delivery: A Systematic Review. In Drug Development and Industrial Pharmacy. https://doi.org/10.1080/03639045.2018.1539497
        9. Khalid, R., Mahmood, S., Sofian, Z. M., Hilles, A. R., Hashim, N. M., & Ge, Y. (2023). Microneedles and Their Application in Transdermal Delivery of Antihypertensive Drugs—A Review. Pharmaceutics, 15(8), 2029. https://doi.org/10.3390/pharmaceutics15082029
        10. Aldawood, F. K., 1, Andar, A., 2, & Desai, S., 3. (2021). A Comprehensive Review of Microneedles: Types, Materials, Processes, Characterizations and Applications. In Gaetano Giammona & Emanuela Fabiola Craparo (Eds.), Polymers (Vol. 13, p. 2815). https://doi.org/10.3390/polym13162815
        11. Lee, H., Song, C., Baik, S., Kim, D., Center for Nanoparticle Research, Institute for Basic Science (IBS), Seoul 08826, Republic of Korea, School of Chemical and Biological Engineering, Institute of Chemical Processes, Seoul National University, Seoul 08826, Republic of Korea, & Elsevier B.V. (2017). Deviceassisted transdermal                         drug delivery. Advanced Drug Delivery Reviews,                                             127, 35–45. http://dx.doi.org/10.1016/j.addr.2017.08.009
        12. Jung, J. H., Jin, S. G., & The Korean Society of Pharmaceutical Sciences and Technology. (n.d.). Microneedle for transdermal drug delivery: current trends and fabrication. In Journal of Pharmaceutical Investigation (Vol. 51, pp. 503–517)
        13. Luo, X., Yang, L., Cui, Y., & The Author(s). (2023). Microneedles: materials, fabrication, and biomedical applications. In Springer Science+Business Media, LLC, Biomedical Microdevices (Vol. 25, p. 20). https://doi.org/10.1007/s10544-023-00658-y
        14. Zhang, X. P., He, Y. T., Li, W. X., Chen, B. Z., Zhang, C. Y., Cui, Y., & Guo, X. D. (2022). An update on biomaterials as microneedle matrixes for biomedical applications. Journal of Materials Chemistry B, 10(32), 6059–6077. https://doi.org/10.1039/d2tb00905f
        15. Al-Japairai, K. a. S., Mahmood, S., Almurisi, S. H., Venugopal, J. R., Hilles, A. R., Azmana, M., & Raman, S. (2020). Current trends in polymer microneedle for transdermal drug delivery. International Journal of Pharmaceutics, 587, 119673. https://doi.org/10.1016/j.ijpharm.2020.119673
        16. Kulkarni, D., Damiri, F., Rojekar, S., Zehravi, M., Ramproshad, S., Dhoke, D., Musale, S., Mulani, A. A., Modak, P., Paradhi, R., & et al. (2022). Recent Advancements in Microneedle Technology for Multifaceted Biomedical Applications. In X. Pan & G. Quan (Eds.), Pharmaceutics (Vol. 14, p. 1097). https://doi.org/10.3390/pharmaceutics14051097
        17. Parhi, R. & N. Divya Supriya. (2019). Review of Microneedle based Transdermal Drug Delivery Systems. In International Journal of Pharmaceutical Sciences and Nanotechnology (pp. 4511–4512) [Journal-article]. https://doi.org/10.37285/ijpsn.2019.12.3.1
        18. Ita, K. (2015). Transdermal Delivery of Drugs with Microneedles—Potential and Challenges. Pharmaceutics, 7(3), 90–105. https://doi.org/10.3390/pharmaceutics7030090
        19. Gupta, J., Gill, H. S., Andrews, S. N., & Prausnitz, M. R. (2011). Kinetics of skin resealing after insertion of microneedles in human subjects. Journal of Controlled Release, 154(2), 148–155. https://doi.org/10.1016/j.jconrel.2011.05.021
        20. Cheung, K., Das, D. B., & Department of Chemical Engineering, Loughborough University, Loughborough, Leicestershire, UK. (2014). Microneedles for drug delivery: trends and progress. Drug Deliv, 1–17. https://doi.org/10.3109/10717544.2014.986309 
        21. Cárcamo-Martínez, A., ´ Mallon, B., Juan Domínguez-Robles, Vora, L. K., Anjani, Q. K., Donnelly, R. F., & School of Pharmacy, Queen’s University Belfast, 97 Lisburn Road, Belfast BT9 7BL, UK. (n.d.). Hollow microneedles: A perspective in biomedical applications. In International Journal of Pharmaceutics (Vol. 599, p. 120455). https://doi.org/10.1016/j.ijpharm.2021.120455
        22. Gill, H. S., Prausnitz, M. R., Wallace H. Coulter Department of Biomedical Engineering at the Georgia Institute of Technology and Emory University, & School of Chemical and Biomolecular Engineering, Georgia Institute of Technology. (2007). Coated microneedles for transdermal delivery. In J Control Release (Vols. 227–237) [Journalarticle]
        23. Chen, Y., Chen, B. Z., Wang, Q. L., Jin, X., & Guo, X. D. (2017). Fabrication of coated polymer microneedles for transdermal     drug delivery. Journal of  Controlled Release,            265, 14–21. https://doi.org/10.1016/j.jconrel.2017.03.383 
        24. Maurya, A., Nanjappa, S. H., Honnavar, S., Salwa, M., & Murthy, S. N. (2018). Rapidly Dissolving Microneedle Patches for Transdermal Iron Replenishment Therapy. Journal of Pharmaceutical Sciences, 107(6), 1642–1647. https://doi.org/10.1016/j.xphs.2018.02.011 
        25. He, J., Zhang, Z., Zheng, X., Li, L., Qi, J., Wu, W., & Lu, Y. (2021). Design and Evaluation of Dissolving Microneedles for Enhanced Dermal Delivery of Propranolol Hydrochloride. Pharmaceutics, 13(4), 579. https://doi.org/10.3390/pharmaceutics13040579 
        26. Naser, Y. A., Tekko, I. A., Vora, L. K., Peng, K., Anjani, Q. K., Greer, B., Elliott, C., McCarthy, H. O., & Donnelly, R. F. (2023). Hydrogel-forming microarray patches with solid dispersion reservoirs for transdermal long-acting microdepot delivery of a hydrophobic drug. Journal of Controlled Release, 356, 416–433. https://doi.org/10.1016/j.jconrel.2023.03.003 
        27. Tucak, A., Sirbubalo, M., Hindija, L., Rahi´C, O., Hadžiabdi´C, J., Muhamedagi´C, K., ?Ceki´C, A., Vrani´C, E., Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Sarajevo, & Department of Machinery Production Engineering, Faculty of Mechanical Engineering, University of Sarajevo. (2020).
        28. Microneedles: Characteristics, Materials, Production Methods and Commercial Development. In Micromachines (Vol. 11, p. 961) [Journal-article]. https://doi.org/10.3390/mi11110961  Microneedles’ Device: Design, Fabrication, and Applications. (2024). In Macromol (Vols. 2024–4, pp. 320–355). https://doi.org/10.3390/macromol4020019 
        29. Evens, T., Malek, O., Castagne, S., Seveno, D., & Van Bael, A. (2020). A novel method for producing solid polymer microneedles using laser ablated moulds in an injection moulding process. Manufacturing Letters, 24, 29–32. https://doi.org/10.1016/j.mfglet.2020.03.009 
        30. Albarahmieh, E., AbuAmmouneh, L., Kaddoura, Z., AbuHantash, F., Alkhalidi, B. A., & Al-Halhouli, A. (2019). Fabrication of Dissolvable Microneedle Patches Using an Innovative Laser-Cut Mould Design to Shortlist Potentially Transungual Delivery Systems: In Vitro Evaluation. AAPS PharmSciTech, 20(5). https://doi.org/10.1208/s12249-019-1429-5
        31. Dave, R., Shinde, S., Kalayil, N., & Budar, A. (2024). Engineering microscopic delivery systems: a review of dissolving microneedle design, fabrication, and function. Micro and Nano Systems Letters, 12(1). https://doi.org/10.1186/s40486-024-00204-2 
        32. Gupta, J., Felner, E. I., & Prausnitz, M. R. (2009). Minimally Invasive Insulin Delivery in Subjects with Type 1 Diabetes Using Hollow Microneedles. Diabetes Technology & Therapeutics, 11(6), 329–337. https://doi.org/10.1089/dia.2008.0103 
        33. Martanto, W., Moore, J. S., Kashlan, O., Kamath, R., Wang, P. M., O’Neal, J. M., & Prausnitz, M. R. (2005).
        34. Microinfusion  Using  Hollow Microneedles. Pharmaceutical Research,                                             23(1),             104–113. https://doi.org/10.1007/s11095-005-8498-8 
        35. McGrath, M. G., Vucen, S., Vrdoljak, A., Kelly, A., O’Mahony, C., Crean, A. M., & Moore, A. (2013). Production of dissolvable microneedles using an atomised spray process: Effect of microneedle composition on skin penetration. European Journal of Pharmaceutics and Biopharmaceutics, 86(2), 200–211. https://doi.org/10.1016/j.ejpb.2013.04.023  Escobar Chávez, J. J., Bonilla Martínez, D., Angélica, M., Villegas González, N., Molina Trinidad, E., Casas
        36. Alancaster, N., & Revilla Vázquez, A. L. (2010). Microneedles: A Valuable Physical Enhancer to Increase Transdermal Drug Delivery. The Journal of Clinical Pharmacology, 51(7), 964–977. https://doi.org/10.1177/0091270010378859 
        37. Amarnani, R., & Shende, P. (2021). Microneedles in diagnostic, treatment and theranostics: An advancement in minimally-invasive delivery system. Biomedical Microdevices, 24(1). https://doi.org/10.1007/s10544-021-00604w 
        38. Bariya, S. H., Gohel, M. C., Mehta, T. A., Sharma, O. P., Department of Pharmaceutics and Pharmaceutical Technology, Institute of Pharmacy, Nirma University, & Department of Pharmaceutics and Pharmaceutical Technology, L. M. College of Pharmacy, Ahmedabad, Gujarat, India. (2011). Microneedles: an emerging transdermal drug delivery system [Journal-article]. Journal of Pharmacy, 64, 11–29. https://doi.org/10.1111/j.2042-7158.2011.01369.x  Agrawal, S., Gandhi, S., Gurjar, P., Saraswathy, N., & Patel, S. (2020). Microneedles: An advancement to transdermal drug delivery system approach. Journal of Applied Pharmaceutical Science, 10(3), 149–159. https://doi.org/10.7324/japs.2020.103019 
        39. Patel, S. R., Lin, A. S. P., Edelhauser, H. F., & Prausnitz, M. R. (2010). Suprachoroidal Drug Delivery to the Back of the Eye Using Hollow Microneedles. Pharmaceutical Research, 28(1), 166–176. https://doi.org/10.1007/s11095-010-0271-y 
        40. Usman, J., Aliyah, A., Nur, J. F., Nirmayanti, N., &Permana, A. (2022). Combinatorial approach of polymeric patches and solid microneedles for improved transdermal delivery of Valsartan: A Proof-of-Concept Study. Biointerface Research in Applied Chemistry, 13(4), 314. https://doi.org/10.33263/briac134.314
        41. Deshpande, A., Mer, V., Patel, D., & Thakkar, H. (2024). Microneedle-assisted transdermal delivery of carvedilol nanosuspension for the treatment of hypertension. RSC Pharmaceutics, 1(3), 472–483. https://doi.org/10.1039/d4pm00038b
        42. Alkhiro, A. R., &Ghareeb, M. M. (2020). Formulation and Evaluation of Iornoxicam as Dissolving Microneedle Patch. Iraqi Journal of Pharmaceutical Sciences ( P-ISSN 1683 - 3597 E-ISSN 2521 - 3512), 29(1), 184–194. https://doi.org/10.31351/vol29iss1pp184-194
        43. Bariya, S. H., Gohel, M. C., Mehta, T. A., & Sharma, O. P. (2011). Microneedles: an emerging transdermal drug delivery system. Journal of Pharmacy and Pharmacology, 64(1), 11–29. https://doi.org/10.1111/j.20427158.2011.01369.x
        44. Tiwari, A., Sharma, S., Soni, P. K., &Paswan, S. K. (2023). Fabrication And Development Of Dissolving Microneedle Patch Of Butorphanol Tartrate. International Journal of Applied Pharmaceutics, 261–271. https://doi.org/10.22159/ijap.2023v15i3.47411 Chen, C., Shyu, V., &
        45. Chen, C. (2018). Dissolving Microneedle Patches for Transdermal Insulin Delivery in Diabetic Mice: Potential for Clinical Applications. Materials, 11(9), 1625. https://doi.org/10.3390/ma11091625
        46. Nasiri, M. I., Vora, L. K., Ershaid, J. A., Peng, K., Tekko, I. A., & Donnelly, R. F. (2021). Nanoemulsionbased dissolving microneedle arrays for enhanced intradermal and transdermal delivery. Drug Delivery and Translational Research, 12(4), 881–896. https://doi.org/10.1007/s13346-021-01107-0
        47. Lee, B., Lee, C., Lahiji, S. F., Jung, U., Chung, G., & Jung, H. (2020). Dissolving Microneedles for Rapid and Painless Local Anesthesia. Pharmaceutics, 12(4), 366. https://doi.org/10.3390/pharmaceutics12040366
        48. Albadr, A. A., Tekko, I. A., Vora, L. K., Ali, A. A., Laverty, G., Donnelly, R. F., & Thakur, R. R. S. (2021). Rapidly dissolving microneedle patch of amphotericin B for intracorneal fungal infections. Drug Delivery and Translational Research, 12(4), 931–943. https://doi.org/10.1007/s13346-021-01032-2
        49. Lee, I., Lin, W., Shu, J., Tsai, S., Chen, C., & Tsai, M. (2016). Formulation of two?layer dissolving polymeric microneedle patches for insulin transdermal delivery in diabetic mice. Journal of Biomedical Materials Research Part A, 105(1), 84–93. https://doi.org/10.1002/jbm.a.35869
        50. Ramöller, I. K., Tekko, I. A., McCarthy, H. O., & Donnelly, R. F. (2019). Rapidly dissolving bilayer microneedle arrays – A minimally invasive transdermal drug delivery system for vitamin B12. International Journal of Pharmaceutics, 566, 299–306. https://doi.org/10.1016/j.ijpharm.2019.05.066
        51. González-Vázquez, P., Larrañeta, E., McCrudden, M. T., Jarrahian, C., Rein-Weston, A., Quintanar-Solares, M., Zehrung, D., McCarthy, H., Courtenay, A. J., & Donnelly, R. F. (2017). Transdermal delivery of gentamicin using dissolving microneedle arrays for potential treatment of neonatal sepsis. Journal of Controlled Release, 265, 30–40. https://doi.org/10.1016/j.jconrel.2017.07.032
        52. Tas, C., Joyce, J. C., Nguyen, H. X., Eangoor, P., Knaack, J. S., Banga, A. K., &Prausnitz, M. R. (2017). Dihydroergotamine mesylate-loaded dissolving microneedle patch made of polyvinylpyrrolidone for management        of acute migraine therapy. Journal   of Controlled Release, 268, 159–165. https://doi.org/10.1016/j.jconrel.2017.10.021
        53. Sullivan, S. P., Koutsonanos, D. G., Del Pilar Martin, M., Lee, J. W., Zarnitsyn, V., Choi, S., Murthy, N., Compans, R. W., Skountzou, I., &Prausnitz, M. R. (2010). Dissolving polymer microneedle patches for influenza vaccination. Nature Medicine, 16(8), 915–920. https://doi.org/10.1038/nm.2182
        54. Kirkby, M., Hutton, A. R., & Donnelly, R. F. (2020). Microneedle Mediated Transdermal Delivery of Protein, Peptide and Antibody Based Therapeutics: Current Status and Future Considerations. Pharmaceutical Research, 37(6). https://doi.org/10.1007/s11095-020-02844-6
        55. Li, Y., Liu, F., Su, C., Yu, B., Liu, D., Chen, H., Lin, D., Yang, C., Zhou, L., Wu, Q., Xia, W., Xie, X., & Tao, J. (2019). Biodegradable Therapeutic Microneedle Patch for Rapid Antihypertensive Treatment. ACS Applied Materials & Interfaces, 11(34), 30575–30584. https://doi.org/10.1021/acsami.9b09697
        56. McCrudden, M. T., Alkilani, A. Z., McCrudden, C. M., McAlister, E., McCarthy, H. O., Woolfson, A. D., & Donnelly, R. F. (2014). Design and physicochemical characterisation of novel dissolving polymeric microneedle arrays for transdermal delivery of high dose, low molecular weight drugs. Journal of Controlled Release, 180, 71–80. https://doi.org/10.1016/j.jconrel.2014.02.007
        57. Almazan, E. A., Castañeda, P. S., Torres, R. D., & Escobar-Chavez, J. J. (2020). Design and Evaluation of Losartan Transdermal Patch by Using Solid Microneedles as A Physical Permeation Enhancer. PubMed, 19(1), 138–152. https://doi.org/10.22037/ijpr.2019.1100912
        58. Nalluri, B. N., Uppuluri, C., Devineni, J., Nayak, A., Nair, K. J., Whiteside, B. R., & Das, D. B. (2017). Effect of microneedles on transdermal permeation enhancement of amlodipine. Drug Delivery and Translational Research, 7(3), 383–394. https://doi.org/10.1007/s13346-017-0361-z
        59. Chen, J., Huang, W., Huang, Z., Liu, S., Ye, Y., Li, Q., & Huang, M. (2017). Fabrication of Tip-Dissolving Microneedles for Transdermal Drug Delivery of Meloxicam. AAPS PharmSciTech, 19(3), 1141–1151. https://doi.org/10.1208/s12249-017-0926-7
        60. Ahmad, Z., Zafar, N., Mahmood, A., Sarfraz, R. M., Latif, R., & Gad, H. A. (2023). Fast dissolving microneedle patch for pronounced systemic delivery of an antihyperlipidemic drug. Pharmaceutical Development and Technology, 28(9), 896–906. https://doi.org/10.1080/10837450.2023.2272863
        61. Rojekar, S., Vora, L. K., Tekko, I. A., Volpe-Zanutto, F., McCarthy, H. O., Vavia, P. R., & Donnelly, R. F. (2021). Etravirine-loaded dissolving microneedle arrays for long-acting delivery. European Journal of Pharmaceutics and Biopharmaceutics, 165, 41–51. https://doi.org/10.1016/j.ejpb.2021.04.024
        62. Avcil, M., Akman, G., Klokkers, J., Jeong, D., & Çelik, A. (2020). Clinical efficacy of dissolvable microneedles armed with anti melanogenic compounds to counter hyperpigmentation. Journal of Cosmetic Dermatology, 20(2), 605–614. https://doi.org/10.1111/jocd.13571
        63. Hamed, R., Nahia, B. J. A., Alkilani, A. Z., Al-Adhami, Y., & Obaidat, R. (2024). Recent Advances in Microneedling-Assisted Cosmetic Applications. Cosmetics, 11(2), 51. https://doi.org/10.3390/cosmetics11020051
        64. Bae, J. S., Nam, S. M., Cha, H. G., & Park, E. S. (2022). A split-face study to evaluate the efficacy of a dissolving microneedle-encapsulated niacinamide skin patch for the reduction of facial hyperpigmentation. Archives of Aesthetic Plastic Surgery, 28(4), 113–118. https://doi.org/10.14730/aaps.2022.00633
        65. Kang, H., Zuo, Z., Lin, R., Yao, M., Han, Y., & Han, J. (2022). The most promising microneedle device: present and future of hyaluronic acid microneedle patch. Drug Delivery, 29(1), 3087–3110. https://doi.org/10.1080/10717544.2022.2125600
        66. Wang, Q., Gan, Z., Wang, X., Li, X., Zhao, L., Li, D., Xu, Z., Mu, C., Ge, L., & Li, D. (2024). Dissolving Hyaluronic Acid-Based Microneedles to Transdermally Deliver Eugenol Combined with Photothermal Therapy for Acne Vulgaris Treatment. ACS Applied Materials & Interfaces, 16(17), 21595–21609. https://doi.org/10.1021/acsami.4c01790
        67. Nair, P., &Tandel, J. (2021). Microneedling: A means of collagen induction therapy. Journal of Dermatology & Dermatologic Surgery, 25(2), 49. https://doi.org/10.4103/jdds.jdds_126_20
        68. Yamagishi, R., Miura, S., Yabu, K., Ando, M., Hachikubo, Y., Yokoyama, Y., Yasuda, K., & Takei, S. (2024). Fabrication Technology of Self-Dissolving Sodium Hyaluronate Gels Ultrafine Microneedles for Medical Applications with UV-Curing Gas-Permeable Mold. Gels, 10(1), 65. https://doi.org/10.3390/gels10010065
        69. Rajput, A., Patil, A., Kandhare, P., &Pawar, A. (2024). Application of Microneedle Arrays in Cosmetics: Promises, Advances, and Challenges. Medicine in Novel Technology and Devices, 100325. https://doi.org/10.1016/j.medntd.2024.100325
        70. Kang, G., Tu, T. N. T., Kim, S., Yang, H., Jang, M., Jo, D., Ryu, J., Baek, J., & Jung, H. (2018). Adenosine  loaded dissolving microneedle patches to improve skin wrinkles, dermal density, elasticity and hydration. International Journal of Cosmetic Science, 40(2), 199–206. https://doi.org/10.1111/ics.12453
        71. Ahmad, Z., Khan, M. I., Siddique, M. I., Sarwar, H. S., Shahnaz, G., Hussain, S. Z., Bukhari, N. I., Hussain, I., & Sohail, M. F. (2020). Fabrication and Characterization of Thiolated Chitosan Microneedle Patch for Transdermal Delivery of Tacrolimus. AAPS PharmSciTech, 21(2). https://doi.org/10.1208/s12249-019-16119
        72. Anwar, I., Zafar, N., Mahmood, A., Zulcaif, Z., & Latif, R. (2024). Sustained release microneedle patch for pronounced systemic delivery of doxazosin mesylate. Bioimpacts. https://doi.org/10.34172/bi.30257
        73. Permana, A. D., Paredes, A. J., Volpe-Zanutto, F., Anjani, Q. K., Utomo, E., & Donnelly, R. F. (2020). Dissolving microneedle-mediated dermal delivery of itraconazole nanocrystals for improved treatment of cutaneous candidiasis. European Journal of Pharmaceutics and Biopharmaceutics, 154, 50–61. https://doi.org/10.1016/j.ejpb.2020.06.025
        74. He, H., Wang, Z., Aikelamu, K., Bai, J., Shen, Q., Gao, X., & Wang, M. (2023). Preparation and In Vitro Characterization of Microneedles Containing Inclusion Complexes Loaded with Progesterone. Pharmaceutics, 15(6), 1765. https://doi.org/10.3390/pharmaceutics15061765
        75. McCrudden, M. T., Alkilani, A. Z., McCrudden, C. M., McAlister, E., McCarthy, H. O., Woolfson, A. D., & Donnelly, R. F. (2014b). Design and physicochemical characterisation of novel dissolving polymeric microneedle arrays for transdermal delivery of high dose, low molecular weight drugs. Journal of Controlled Release, 180, 71–80. https://doi.org/10.1016/j.jconrel.2014.02.007
        76. Ananda, P. W. R., Elim, D., Zaman, H. S., Muslimin, W., Tunggeng, M. G. R., &Permana, A. D. (2021). Combination of transdermal patches and solid microneedles for improved transdermal delivery of primaquine. International Journal of Pharmaceutics, 609, 121204. https://doi.org/10.1016/j.ijpharm.2021.121204
        77. Li, Y., Liu, F., Su, C., Yu, B., Liu, D., Chen, H., Lin, D., Yang, C., Zhou, L., Wu, Q., Xia, W., Xie, X., & Tao, J. (2019b). Biodegradable Therapeutic Microneedle Patch for Rapid Antihypertensive Treatment. ACS Applied Materials & Interfaces, 11(34), 30575–30584. https://doi.org/10.1021/acsami.9b09697
        78. Ameri, M., Kadkhodayan, M., Nguyen, J., Bravo, J., Su, R., Chan, K., Samiee, A., &Daddona, P. (2014). Human Growth Hormone Delivery with a Microneedle Transdermal System: Preclinical Formulation, Stability, Delivery and PK of Therapeutically Relevant Doses. Pharmaceutics, 6(2), 220–234. https://doi.org/10.3390/pharmaceutics6020220
        79. Pamornpathomkul, B., Ngawhirunpat, T., Tekko, I. A., Vora, L., McCarthy, H. O., & Donnelly, R. F. (2018). Dissolving polymeric microneedle arrays for enhanced site-specific acyclovir delivery. European Journal of Pharmaceutical Sciences, 121, 200–209. https://doi.org/10.1016/j.ejps.2018.05.009
        80. Bhatnagar, S., Saju, A., Cheerla, K. D., Gade, S. K., Garg, P., & Venuganti, V. V. K. (2017). Corneal delivery of besifloxacin using rapidly dissolving polymeric microneedles. Drug Delivery and Translational Research, 8(3), 473–483. https://doi.org/10.1007/s13346-017-0470-8
        81. Alwan LA, Al-Akkam EJ. Formulation and Evaluation of Transdermal Dissolved Microneedles Patches for Meloxicam. International Journal of Drug Delivery Technology. 2021;11(3):656-662.
        82. Surekha, B., Misra, P., Thippaiah, A. C., Shamanna, B. R., Madathil, A., &Rajadurai, M. (2024). A Microneedle Transdermal Patch loaded with Iron(II) Nanoparticles for Non-invasive Sustained Delivery to Combat Anemia. Materials Advances. https://doi.org/10.1039/d3ma01166f
        83. Kumar, M. K., Inamadar, A. C., & Palit, A. (2018). A randomized controlled, single-observer blinded study to determine the efficacy of topical minoxidil plus microneedling versus topical minoxidil alone in the treatment of androgenetic alopecia. Journal of Cutaneous and Aesthetic Surgery, 11(4), 211. https://doi.org/10.4103/jcas.jcas_130_17
        84. McAlister, E., Kearney, MC., Martin, E.L. et al. From the laboratory to the end-user: a primary packaging study for microneedle patches containing amoxicillin sodium. Drug Deliv. and Transl. Res. 11, 2169–2185 (2021). https://doi.org/10.1007/s13346-020-00883-5
        85. Li, Y., Vora, L. K., Wang, J., Sabri, A. H. B., Graham, A., McCarthy, H. O., & Donnelly, R. F. (2024). Poly(acrylic acid)/Poly(vinyl alcohol) Microarray Patches for Continuous Transdermal Delivery of Levodopa and Carbidopa: In Vitro and In Vivo                                    Studies. Pharmaceutics,        16(5), 676. https://doi.org/10.3390/pharmaceutics16050676
        86. Wang, C., Huang, X., Tang, Z., Zhang, Y., Wei, M., Du, S., Song, X., Wu, Y., Chi, Q., Zhuang, X., Lina, D., & Jin, Y. (2024). Dissolving microneedles loaded with nimodipine for prevention of sleep disorders at a high altitude. Pharmaceutical Development and Technology, 29(5), 415–428. https://doi.org/10.1080/10837450.2024.2342965
        87. Al-Shaibani, A. J. N., & Ghareeb, M. M. (2024). Formulation, in vitro and in vivo evaluation of olanzapine nanoparticles dissolving microneedles for transdermal delivery. Pharmacia, 71, 1–13. https://doi.org/10.3897/pharmacia.71.e120974
        88. Rapoport, A. M., Ameri, M., Lewis, H., & Kellerman, D. J. (2020). Development of a novel zolmitriptanintracutaneous microneedle system (QtryptaTM) for the acute treatment of migraine. Pain Management, 10(6), 359–366. https://doi.org/10.2217/pmt-2020-0041
        89. Zhang, T., Sun, B., Guo, J., Wang, M., Cui, H., Mao, H., Wang, B., & Yan, F. (2020). Active pharmaceutical ingredient poly(ionic liquid)-based microneedles for the treatment of skin acne infection. ActaBiomaterialia, 115, 136–147. https://doi.org/10.1016/j.actbio.2020.08.023
        90. Sim, J., Kang, G., Yang, H., Jang, M., Kim, Y., Ahn, H., Kim, M., & Jung, H. (2022). Development of Clinical Weekly-Dose Teriparatide Acetate Encapsulated Dissolving Microneedle Patch for Efficient Treatment of Osteoporosis. Polymers, 14(19), 4027. https://doi.org/10.3390/polym14194027
        91. Koutsonanos, D. G., Compans, R. W., &Skountzou, I. (2013). Targeting the Skin for Microneedle Delivery of Influenza Vaccine. Advances in Experimental Medicine and Biology, 121–132. https://doi.org/10.1007/978-1-4614-6217-0_13
        92. Li, G., Badkar, A., Nema, S., Kolli, C. S., &Banga, A. K. (2008). In vitro transdermal delivery of therapeutic antibodies using maltose microneedles. International Journal of Pharmaceutics, 368(1–2), 109–115. https://doi.org/10.1016/j.ijpharm.2008.10.008
        93. Aich, K., Singh, T., & Dang, S. (2021). Advances in microneedle-based transdermal delivery for drugs and peptides. Drug Delivery and Translational Research, 12(7), 1556–1568. https://doi.org/10.1007/s13346-02101056-8
        94. Kirkby, M., Hutton, A. R., & Donnelly, R. F. (2020). Microneedle Mediated Transdermal Delivery of Protein, Peptide and Antibody Based Therapeutics: Current Status and Future Considerations. Pharmaceutical Research, 37(6). https://doi.org/10.1007/s11095-020-02844-6
        95. Sun, W., Inayathullah, M., Manoukian, M. a. C., Malkovskiy, A. V., Manickam, S., Marinkovich, M. P., Lane, A. T., Tayebi, L., Seifalian, A. M., & Rajadas, J. (2015). Transdermal Delivery of Functional Collagen Via Polyvinylpyrrolidone Microneedles. Annals of Biomedical Engineering, 43(12), 2978–2990. https://doi.org/10.1007/s10439-015-1353-0
        96. Lee, Y., Kumar, S., Kim, S. H., Seong, K., Lee, H., Kim, C., Jung, Y., & Yang, S. Y. (2020). Odorless Glutathione Microneedle Patches for Skin Whitening. Pharmaceutics, 12(2), 100. https://doi.org/10.3390/pharmaceutics12020100
        97. Shin, C. I., Kim, M., & Kim, Y. (2019b). Delivery of Niacinamide to the Skin Using Microneedle-Like Particles. Pharmaceutics, 11(7), 326. https://doi.org/10.3390/pharmaceutics11070326
        98. Hiraishi, Y., Nakagawa, T., Quan, Y., Kamiyama, F., Hirobe, S., Okada, N., & Nakagawa, S. (2012). Performance and characteristics evaluation of a sodium hyaluronate-based microneedle patch for a transcutaneous drug delivery system. International Journal of Pharmaceutics, 441(1–2), 570–579. https://doi.org/10.1016/j.ijpharm.2012.10.042
        99. Feng, X., Su, H., &Xie, J. (2023). The efficacy and safety of microneedling with topical tranexamic acid for melasma treatment: A systematic review and meta analysis. Journal of Cosmetic Dermatology, 23(1), 33–43. https://doi.org/10.1111/jocd.15965
        100. Khorshidian, A., Sharifi, N., Kheirabadi, F. C., Rezaei, F., Sheikholeslami, S. A., Ariyannejad, A., Esmaeili, J., Basati, H., &Barati, A. (2024). In Vitro Release of GlycyrrhizaGlabra Extract by a Gel-Based Microneedle Patch for Psoriasis Treatment. Gels, 10(2), 87. https://doi.org/10.3390/gels10020087
        101. Ding Zhi, Liu Yang, & Zhang Junfeng. (2020, January 19). CN113133991B - Colchicine soluble microneedle patch and preparation method thereof   - Google Patents.  https://patents.google.com/patent/CN113133991B/en
        102. Zhang Yanfeng, Chen Yongli, Zhang Kaimin, Gan Miao, GuLihong, Zou Zhirong, Huang Weilin,& Ltd, S. U. B. C. (2023, February 8).CN116270666A – Patch for treating dermatophyte infection and preparation method thereof - Google Patents. https://patents.google.com/patent/CN116270666A/en?oq=CN116270666A
        103. Xia Denning, Lin Hongbing, & Pei Dandi. (2023, February 28). CN116350751A - Liraglutide microneedle patch and preparation method and application thereof  - Google Patents. https://patents.google.com/patent/CN116350751A/en?oq=CN116350751A 
        104. Lin Xiaoxi, Zhang Shiren, QiuYajing, & Liu Yun. (2023, April 11). CN116421874A - Soluble microneedle patch carrying anti-hemangioma drug and preparation method thereof   - Google Patents. https://patents.google.com/patent/CN116421874A/en?oq=CN116421874A 
        105. Baek Kyeong-rae, Choi Jae-min, &Dermajec. (2023, January 10). KR102563820B1 - A microneedle for brightening which stabilizes vitamin c or derivatives thereof using antioxidant-network,substances-Google-Patents. https://patents.google.com/patent/KR102563820B1/en?oq=KR102563820B1
        106. Ding Xin, Liang Yijing, & Yuan Peiyan. (2023, April 27). CN116617150A - Antifungal microneedle patch and preparation method and application thereof   - Google Patents. https://patents.google.com/patent/CN116617150A/en?oq=CN116617150A
        107. Shuai Xintao, Wang Jiachen, Huang Sicong, Wei Huiye, & Lin Minzhao(2023, July 24). CN116687833A - Soluble microneedle containing antibody-coupled albumin taxolnano-drug and preparation method and application thereof   - Google Patents. https://patents.google.com/patent/CN116687833A/en?oq=CN116687833A 
        108. Xing Chengfen, Zhang Ran, Li Hao, & Zhan Yong. (2023, July 25). CN116725939A - Soluble hyaluronic acid drugloadedmicroneedle and preparation method thereof  - Google Patents. https://patents.google.com/patent/CN116725939A/en?oq=CN116725939A
        109. Chen Xuheng, Wan Guoyun, Gou Ruiling, Chen Hongli, Wang Haijiao, Li Yaojia, Chang Jiaxin, Chen Jiayu, Li Xiaoyu, & Guan Chenguang. (2023, July 24). CN116763715A - Preparation method and application of paeonol-soluble transdermal microneedle for treating psoriasis-Google-Patents.  https://patents.google.com/patent/CN116763715A/en?oq=CN116763715A
        110. Du Jie, Wang Yuan, GuoXindong, Li Dehui, & He Yuting. (2023, June 15). CN116440062B - Soluble microneedle patch carrying levosimendan for treating heart failure and preparation method,thereof-Google-Patents. https://patents.google.com/patent/CN116440062B/en?oq=CN116440062B
        111. Henke, S., Henning, A., Pracht, R., Brodkorb, D., Scherr, S., & Ag, L. L. T. S. (2018b, April 19).  US20230330010A1 - Microneedle system for the delivery of interferon   - Google Patents.  https://patents.google.com/patent/US20230330010A1/en?oq=US20230330010A1 
        112. Qu Yan, Yang Qin, ZhongGuofeng, Zhang Chen, Zeng Rui, Gou Kaijun, & Wang Xiao. (2023, August 21). CN116763716A - Bletilla polysaccharide microneedle carrying ginsenoside Rg3 and preparation method and application thereof - Google Patents. https://patents.google.com/patent/CN116763716A/en?oq=CN116763716A 
        113. Wang Mei, Shen Qi, & He Hongji.(2023, August 22). CN117018422A - Preparation method of progesterone liposome slow release microneedle  - Google Patents. https://patents.google.com/patent/CN117018422A/en?oq=CN117018422A
        114. Qian Haisheng, Zheng Wang, Chu Zhaoyou, Wang Wanni, Xu Linling, Ma Yan, & Wang Peisan. (2023, November 10). CN117258131A - Microneedle patch loaded with sparfloxacin and manganese-based nanodrugs and application of microneedle patch in-situ triple negative breast cancer and lung metastasis treatment   - Google Patents. https://patents.google.com/patent/CN117258131A/en?oq=CN117258131A
        115. Li Wei, Chen Chuang, Zhang Wen, &JinYinli. (2023, October 30). CN117503682A - Levothyroxine sodiumloaded microcrystalline biphasic microneedle patch for treating hypothyroidism by combining mussel-like adhesion material, and preparation method and application thereof    - Google Patents. https://patents.google.com/patent/CN117503682A/en?oq=CN117503682A
        116. Su Qing, Tang Shuai, Su Xiaomeng, Xu Fengqian, & Sun Tong. (2023, December 11). CN117598988A - Dutasteride nano suspension, soluble microneedle and preparation method thereof   - Google Patents. https://patents.google.com/patent/CN117598988A/en?oq=CN117598988A
        117. Mira Jo, Joong-ho Lee, Sun-young Lee, A-ram Lee, Jeong-won Choi, Hyun-sik Na, Geun-hyeong Cho, Chaerim Lee, Su-bin Jeon, & Industry-Academic Cooperation Unit(2023, January 26). KR20240117782A - Composition for skin patch and injection treatment for keloid,treatment-Google-Patents. https://patents.google.com/patent/KR20240117782A/en?oq=KR20240117782A
        118. Gou Maling, & Jiang Xuebing.(2023, March 10). CN118615229A - Lidocaine hydrochloride microneedle patch, preparation method thereof and application of isomaltulose alcohol in microneedle,patch-Google-Patents. https://patents.google.com/patent/CN118615229A/en?oq=CN118615229A
        119. Wang, L., &Cotsarelis, G. (2023, March 8). WO2024187056A2 - Minoxidil-crosslinked injectable hydrogels for local and sustained intradermal delivery   - Google Patents. https://patents.google.com/patent/WO2024187056A2/en?oq=WO2024187056A2
        120. Fakih, H. H., Sleiman, H., Khvorova, A., Tang, Q., Harris, J. E., Alterman, J. F., Abideen, M. Z. U., & Furgal, R. (2023, March 3). WO2024186627A1 - Topical delivery of therapeutic oligonucleotides    - Google Patents. https://patents.google.com/patent/WO2024186627A1/en?oq=WO2024186627A1.

Reference

  1. Singhal, P., , Singhal, R., Kumar, V., Goel, K. K., Jangra, A. K., & Yadav, R. (2012). Transdermal Drug Delivery System: A Novel Technique To Enhance Therapeutic Efficacy And Safety Of Drugs [Review Article]. American Journal of PharmTech Research, 106–107. http://www.ajptr.com/ (Original work published 2012)
  2. Tanwar, H., & Sachdeva, R. (2016). Transdermal Drug Delivery System: A Review. International Journal of Pharmaceutical Sciences and Research, 7(6). https://doi.org/10.13040/ijpsr.09758232.7(6).2274-90
  3. Yousef, H., Alhajj, M., Fakoya, A. O., & Sharma, S. (2024, June 8). Anatomy, Skin (Integument), Epidermis. StatPearls - NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK470464/
  4. Yu, Y., Yang, X., Wu, X., & Fan, Y. (2021). Enhancing Permeation of Drug Molecules Across the Skin via Delivery in Nanocarriers: Novel Strategies for Effective Transdermal Applications. Frontiers in Bioengineering and Biotechnology, 9. https://doi.org/10.3389/fbioe.2021.646554.
  5. Khan, S., & Sharman, T. (2023, February 6). Transdermal Medications. StatPearls - NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK556035/
  6. Golhar, A.  (2020). Introduction   to Novel Drug Delivery System. Unipune. https://www.academia.edu/43564084/Introduction_to_Novel_Drug_Delivery_System
  7. Halder, J., Gupta, S., Kumari, R., Gupta, G. D., & Rai, V. K. (2020). Microneedle Array: Applications, Recent Advances, and Clinical Pertinence in Transdermal Drug Delivery. Journal of Pharmaceutical Innovation, 16(3), 558–565. https://doi.org/10.1007/s12247-020-09460-2
  8. Dharadhar, S., Majumdar, A. S., Bombay College of Pharmacy, Dhoble, S., Institute of Chemical Technology, Mumbai, Patravale, V., & Institute of Chemical Technology, Mumbai. (2018). Microneedles for Transdermal Drug Delivery: A Systematic Review. In Drug Development and Industrial Pharmacy. https://doi.org/10.1080/03639045.2018.1539497
  9. Khalid, R., Mahmood, S., Sofian, Z. M., Hilles, A. R., Hashim, N. M., & Ge, Y. (2023). Microneedles and Their Application in Transdermal Delivery of Antihypertensive Drugs—A Review. Pharmaceutics, 15(8), 2029. https://doi.org/10.3390/pharmaceutics15082029
  10. Aldawood, F. K., 1, Andar, A., 2, & Desai, S., 3. (2021). A Comprehensive Review of Microneedles: Types, Materials, Processes, Characterizations and Applications. In Gaetano Giammona & Emanuela Fabiola Craparo (Eds.), Polymers (Vol. 13, p. 2815). https://doi.org/10.3390/polym13162815
  11. Lee, H., Song, C., Baik, S., Kim, D., Center for Nanoparticle Research, Institute for Basic Science (IBS), Seoul 08826, Republic of Korea, School of Chemical and Biological Engineering, Institute of Chemical Processes, Seoul National University, Seoul 08826, Republic of Korea, & Elsevier B.V. (2017). Deviceassisted transdermal                         drug delivery. Advanced Drug Delivery Reviews,                                             127, 35–45. http://dx.doi.org/10.1016/j.addr.2017.08.009
  12. Jung, J. H., Jin, S. G., & The Korean Society of Pharmaceutical Sciences and Technology. (n.d.). Microneedle for transdermal drug delivery: current trends and fabrication. In Journal of Pharmaceutical Investigation (Vol. 51, pp. 503–517)
  13. Luo, X., Yang, L., Cui, Y., & The Author(s). (2023). Microneedles: materials, fabrication, and biomedical applications. In Springer Science+Business Media, LLC, Biomedical Microdevices (Vol. 25, p. 20). https://doi.org/10.1007/s10544-023-00658-y
  14. Zhang, X. P., He, Y. T., Li, W. X., Chen, B. Z., Zhang, C. Y., Cui, Y., & Guo, X. D. (2022). An update on biomaterials as microneedle matrixes for biomedical applications. Journal of Materials Chemistry B, 10(32), 6059–6077. https://doi.org/10.1039/d2tb00905f
  15. Al-Japairai, K. a. S., Mahmood, S., Almurisi, S. H., Venugopal, J. R., Hilles, A. R., Azmana, M., & Raman, S. (2020). Current trends in polymer microneedle for transdermal drug delivery. International Journal of Pharmaceutics, 587, 119673. https://doi.org/10.1016/j.ijpharm.2020.119673
  16. Kulkarni, D., Damiri, F., Rojekar, S., Zehravi, M., Ramproshad, S., Dhoke, D., Musale, S., Mulani, A. A., Modak, P., Paradhi, R., & et al. (2022). Recent Advancements in Microneedle Technology for Multifaceted Biomedical Applications. In X. Pan & G. Quan (Eds.), Pharmaceutics (Vol. 14, p. 1097). https://doi.org/10.3390/pharmaceutics14051097
  17. Parhi, R. & N. Divya Supriya. (2019). Review of Microneedle based Transdermal Drug Delivery Systems. In International Journal of Pharmaceutical Sciences and Nanotechnology (pp. 4511–4512) [Journal-article]. https://doi.org/10.37285/ijpsn.2019.12.3.1
  18. Ita, K. (2015). Transdermal Delivery of Drugs with Microneedles—Potential and Challenges. Pharmaceutics, 7(3), 90–105. https://doi.org/10.3390/pharmaceutics7030090
  19. Gupta, J., Gill, H. S., Andrews, S. N., & Prausnitz, M. R. (2011). Kinetics of skin resealing after insertion of microneedles in human subjects. Journal of Controlled Release, 154(2), 148–155. https://doi.org/10.1016/j.jconrel.2011.05.021
  20. Cheung, K., Das, D. B., & Department of Chemical Engineering, Loughborough University, Loughborough, Leicestershire, UK. (2014). Microneedles for drug delivery: trends and progress. Drug Deliv, 1–17. https://doi.org/10.3109/10717544.2014.986309 
  21. Cárcamo-Martínez, A., ´ Mallon, B., Juan Domínguez-Robles, Vora, L. K., Anjani, Q. K., Donnelly, R. F., & School of Pharmacy, Queen’s University Belfast, 97 Lisburn Road, Belfast BT9 7BL, UK. (n.d.). Hollow microneedles: A perspective in biomedical applications. In International Journal of Pharmaceutics (Vol. 599, p. 120455). https://doi.org/10.1016/j.ijpharm.2021.120455
  22. Gill, H. S., Prausnitz, M. R., Wallace H. Coulter Department of Biomedical Engineering at the Georgia Institute of Technology and Emory University, & School of Chemical and Biomolecular Engineering, Georgia Institute of Technology. (2007). Coated microneedles for transdermal delivery. In J Control Release (Vols. 227–237) [Journalarticle]
  23. Chen, Y., Chen, B. Z., Wang, Q. L., Jin, X., & Guo, X. D. (2017). Fabrication of coated polymer microneedles for transdermal     drug delivery. Journal of  Controlled Release,            265, 14–21. https://doi.org/10.1016/j.jconrel.2017.03.383 
  24. Maurya, A., Nanjappa, S. H., Honnavar, S., Salwa, M., & Murthy, S. N. (2018). Rapidly Dissolving Microneedle Patches for Transdermal Iron Replenishment Therapy. Journal of Pharmaceutical Sciences, 107(6), 1642–1647. https://doi.org/10.1016/j.xphs.2018.02.011 
  25. He, J., Zhang, Z., Zheng, X., Li, L., Qi, J., Wu, W., & Lu, Y. (2021). Design and Evaluation of Dissolving Microneedles for Enhanced Dermal Delivery of Propranolol Hydrochloride. Pharmaceutics, 13(4), 579. https://doi.org/10.3390/pharmaceutics13040579 
  26. Naser, Y. A., Tekko, I. A., Vora, L. K., Peng, K., Anjani, Q. K., Greer, B., Elliott, C., McCarthy, H. O., & Donnelly, R. F. (2023). Hydrogel-forming microarray patches with solid dispersion reservoirs for transdermal long-acting microdepot delivery of a hydrophobic drug. Journal of Controlled Release, 356, 416–433. https://doi.org/10.1016/j.jconrel.2023.03.003 
  27. Tucak, A., Sirbubalo, M., Hindija, L., Rahi´C, O., Hadžiabdi´C, J., Muhamedagi´C, K., ?Ceki´C, A., Vrani´C, E., Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Sarajevo, & Department of Machinery Production Engineering, Faculty of Mechanical Engineering, University of Sarajevo. (2020).
  28. Microneedles: Characteristics, Materials, Production Methods and Commercial Development. In Micromachines (Vol. 11, p. 961) [Journal-article]. https://doi.org/10.3390/mi11110961  Microneedles’ Device: Design, Fabrication, and Applications. (2024). In Macromol (Vols. 2024–4, pp. 320–355). https://doi.org/10.3390/macromol4020019 
  29. Evens, T., Malek, O., Castagne, S., Seveno, D., & Van Bael, A. (2020). A novel method for producing solid polymer microneedles using laser ablated moulds in an injection moulding process. Manufacturing Letters, 24, 29–32. https://doi.org/10.1016/j.mfglet.2020.03.009 
  30. Albarahmieh, E., AbuAmmouneh, L., Kaddoura, Z., AbuHantash, F., Alkhalidi, B. A., & Al-Halhouli, A. (2019). Fabrication of Dissolvable Microneedle Patches Using an Innovative Laser-Cut Mould Design to Shortlist Potentially Transungual Delivery Systems: In Vitro Evaluation. AAPS PharmSciTech, 20(5). https://doi.org/10.1208/s12249-019-1429-5
  31. Dave, R., Shinde, S., Kalayil, N., & Budar, A. (2024). Engineering microscopic delivery systems: a review of dissolving microneedle design, fabrication, and function. Micro and Nano Systems Letters, 12(1). https://doi.org/10.1186/s40486-024-00204-2 
  32. Gupta, J., Felner, E. I., & Prausnitz, M. R. (2009). Minimally Invasive Insulin Delivery in Subjects with Type 1 Diabetes Using Hollow Microneedles. Diabetes Technology & Therapeutics, 11(6), 329–337. https://doi.org/10.1089/dia.2008.0103 
  33. Martanto, W., Moore, J. S., Kashlan, O., Kamath, R., Wang, P. M., O’Neal, J. M., & Prausnitz, M. R. (2005).
  34. Microinfusion  Using  Hollow Microneedles. Pharmaceutical Research,                                             23(1),             104–113. https://doi.org/10.1007/s11095-005-8498-8 
  35. McGrath, M. G., Vucen, S., Vrdoljak, A., Kelly, A., O’Mahony, C., Crean, A. M., & Moore, A. (2013). Production of dissolvable microneedles using an atomised spray process: Effect of microneedle composition on skin penetration. European Journal of Pharmaceutics and Biopharmaceutics, 86(2), 200–211. https://doi.org/10.1016/j.ejpb.2013.04.023  Escobar Chávez, J. J., Bonilla Martínez, D., Angélica, M., Villegas González, N., Molina Trinidad, E., Casas
  36. Alancaster, N., & Revilla Vázquez, A. L. (2010). Microneedles: A Valuable Physical Enhancer to Increase Transdermal Drug Delivery. The Journal of Clinical Pharmacology, 51(7), 964–977. https://doi.org/10.1177/0091270010378859 
  37. Amarnani, R., & Shende, P. (2021). Microneedles in diagnostic, treatment and theranostics: An advancement in minimally-invasive delivery system. Biomedical Microdevices, 24(1). https://doi.org/10.1007/s10544-021-00604w 
  38. Bariya, S. H., Gohel, M. C., Mehta, T. A., Sharma, O. P., Department of Pharmaceutics and Pharmaceutical Technology, Institute of Pharmacy, Nirma University, & Department of Pharmaceutics and Pharmaceutical Technology, L. M. College of Pharmacy, Ahmedabad, Gujarat, India. (2011). Microneedles: an emerging transdermal drug delivery system [Journal-article]. Journal of Pharmacy, 64, 11–29. https://doi.org/10.1111/j.2042-7158.2011.01369.x  Agrawal, S., Gandhi, S., Gurjar, P., Saraswathy, N., & Patel, S. (2020). Microneedles: An advancement to transdermal drug delivery system approach. Journal of Applied Pharmaceutical Science, 10(3), 149–159. https://doi.org/10.7324/japs.2020.103019 
  39. Patel, S. R., Lin, A. S. P., Edelhauser, H. F., & Prausnitz, M. R. (2010). Suprachoroidal Drug Delivery to the Back of the Eye Using Hollow Microneedles. Pharmaceutical Research, 28(1), 166–176. https://doi.org/10.1007/s11095-010-0271-y 
  40. Usman, J., Aliyah, A., Nur, J. F., Nirmayanti, N., &Permana, A. (2022). Combinatorial approach of polymeric patches and solid microneedles for improved transdermal delivery of Valsartan: A Proof-of-Concept Study. Biointerface Research in Applied Chemistry, 13(4), 314. https://doi.org/10.33263/briac134.314
  41. Deshpande, A., Mer, V., Patel, D., & Thakkar, H. (2024). Microneedle-assisted transdermal delivery of carvedilol nanosuspension for the treatment of hypertension. RSC Pharmaceutics, 1(3), 472–483. https://doi.org/10.1039/d4pm00038b
  42. Alkhiro, A. R., &Ghareeb, M. M. (2020). Formulation and Evaluation of Iornoxicam as Dissolving Microneedle Patch. Iraqi Journal of Pharmaceutical Sciences ( P-ISSN 1683 - 3597 E-ISSN 2521 - 3512), 29(1), 184–194. https://doi.org/10.31351/vol29iss1pp184-194
  43. Bariya, S. H., Gohel, M. C., Mehta, T. A., & Sharma, O. P. (2011). Microneedles: an emerging transdermal drug delivery system. Journal of Pharmacy and Pharmacology, 64(1), 11–29. https://doi.org/10.1111/j.20427158.2011.01369.x
  44. Tiwari, A., Sharma, S., Soni, P. K., &Paswan, S. K. (2023). Fabrication And Development Of Dissolving Microneedle Patch Of Butorphanol Tartrate. International Journal of Applied Pharmaceutics, 261–271. https://doi.org/10.22159/ijap.2023v15i3.47411 Chen, C., Shyu, V., &
  45. Chen, C. (2018). Dissolving Microneedle Patches for Transdermal Insulin Delivery in Diabetic Mice: Potential for Clinical Applications. Materials, 11(9), 1625. https://doi.org/10.3390/ma11091625
  46. Nasiri, M. I., Vora, L. K., Ershaid, J. A., Peng, K., Tekko, I. A., & Donnelly, R. F. (2021). Nanoemulsionbased dissolving microneedle arrays for enhanced intradermal and transdermal delivery. Drug Delivery and Translational Research, 12(4), 881–896. https://doi.org/10.1007/s13346-021-01107-0
  47. Lee, B., Lee, C., Lahiji, S. F., Jung, U., Chung, G., & Jung, H. (2020). Dissolving Microneedles for Rapid and Painless Local Anesthesia. Pharmaceutics, 12(4), 366. https://doi.org/10.3390/pharmaceutics12040366
  48. Albadr, A. A., Tekko, I. A., Vora, L. K., Ali, A. A., Laverty, G., Donnelly, R. F., & Thakur, R. R. S. (2021). Rapidly dissolving microneedle patch of amphotericin B for intracorneal fungal infections. Drug Delivery and Translational Research, 12(4), 931–943. https://doi.org/10.1007/s13346-021-01032-2
  49. Lee, I., Lin, W., Shu, J., Tsai, S., Chen, C., & Tsai, M. (2016). Formulation of two?layer dissolving polymeric microneedle patches for insulin transdermal delivery in diabetic mice. Journal of Biomedical Materials Research Part A, 105(1), 84–93. https://doi.org/10.1002/jbm.a.35869
  50. Ramöller, I. K., Tekko, I. A., McCarthy, H. O., & Donnelly, R. F. (2019). Rapidly dissolving bilayer microneedle arrays – A minimally invasive transdermal drug delivery system for vitamin B12. International Journal of Pharmaceutics, 566, 299–306. https://doi.org/10.1016/j.ijpharm.2019.05.066
  51. González-Vázquez, P., Larrañeta, E., McCrudden, M. T., Jarrahian, C., Rein-Weston, A., Quintanar-Solares, M., Zehrung, D., McCarthy, H., Courtenay, A. J., & Donnelly, R. F. (2017). Transdermal delivery of gentamicin using dissolving microneedle arrays for potential treatment of neonatal sepsis. Journal of Controlled Release, 265, 30–40. https://doi.org/10.1016/j.jconrel.2017.07.032
  52. Tas, C., Joyce, J. C., Nguyen, H. X., Eangoor, P., Knaack, J. S., Banga, A. K., &Prausnitz, M. R. (2017). Dihydroergotamine mesylate-loaded dissolving microneedle patch made of polyvinylpyrrolidone for management        of acute migraine therapy. Journal   of Controlled Release, 268, 159–165. https://doi.org/10.1016/j.jconrel.2017.10.021
  53. Sullivan, S. P., Koutsonanos, D. G., Del Pilar Martin, M., Lee, J. W., Zarnitsyn, V., Choi, S., Murthy, N., Compans, R. W., Skountzou, I., &Prausnitz, M. R. (2010). Dissolving polymer microneedle patches for influenza vaccination. Nature Medicine, 16(8), 915–920. https://doi.org/10.1038/nm.2182
  54. Kirkby, M., Hutton, A. R., & Donnelly, R. F. (2020). Microneedle Mediated Transdermal Delivery of Protein, Peptide and Antibody Based Therapeutics: Current Status and Future Considerations. Pharmaceutical Research, 37(6). https://doi.org/10.1007/s11095-020-02844-6
  55. Li, Y., Liu, F., Su, C., Yu, B., Liu, D., Chen, H., Lin, D., Yang, C., Zhou, L., Wu, Q., Xia, W., Xie, X., & Tao, J. (2019). Biodegradable Therapeutic Microneedle Patch for Rapid Antihypertensive Treatment. ACS Applied Materials & Interfaces, 11(34), 30575–30584. https://doi.org/10.1021/acsami.9b09697
  56. McCrudden, M. T., Alkilani, A. Z., McCrudden, C. M., McAlister, E., McCarthy, H. O., Woolfson, A. D., & Donnelly, R. F. (2014). Design and physicochemical characterisation of novel dissolving polymeric microneedle arrays for transdermal delivery of high dose, low molecular weight drugs. Journal of Controlled Release, 180, 71–80. https://doi.org/10.1016/j.jconrel.2014.02.007
  57. Almazan, E. A., Castañeda, P. S., Torres, R. D., & Escobar-Chavez, J. J. (2020). Design and Evaluation of Losartan Transdermal Patch by Using Solid Microneedles as A Physical Permeation Enhancer. PubMed, 19(1), 138–152. https://doi.org/10.22037/ijpr.2019.1100912
  58. Nalluri, B. N., Uppuluri, C., Devineni, J., Nayak, A., Nair, K. J., Whiteside, B. R., & Das, D. B. (2017). Effect of microneedles on transdermal permeation enhancement of amlodipine. Drug Delivery and Translational Research, 7(3), 383–394. https://doi.org/10.1007/s13346-017-0361-z
  59. Chen, J., Huang, W., Huang, Z., Liu, S., Ye, Y., Li, Q., & Huang, M. (2017). Fabrication of Tip-Dissolving Microneedles for Transdermal Drug Delivery of Meloxicam. AAPS PharmSciTech, 19(3), 1141–1151. https://doi.org/10.1208/s12249-017-0926-7
  60. Ahmad, Z., Zafar, N., Mahmood, A., Sarfraz, R. M., Latif, R., & Gad, H. A. (2023). Fast dissolving microneedle patch for pronounced systemic delivery of an antihyperlipidemic drug. Pharmaceutical Development and Technology, 28(9), 896–906. https://doi.org/10.1080/10837450.2023.2272863
  61. Rojekar, S., Vora, L. K., Tekko, I. A., Volpe-Zanutto, F., McCarthy, H. O., Vavia, P. R., & Donnelly, R. F. (2021). Etravirine-loaded dissolving microneedle arrays for long-acting delivery. European Journal of Pharmaceutics and Biopharmaceutics, 165, 41–51. https://doi.org/10.1016/j.ejpb.2021.04.024
  62. Avcil, M., Akman, G., Klokkers, J., Jeong, D., & Çelik, A. (2020). Clinical efficacy of dissolvable microneedles armed with anti melanogenic compounds to counter hyperpigmentation. Journal of Cosmetic Dermatology, 20(2), 605–614. https://doi.org/10.1111/jocd.13571
  63. Hamed, R., Nahia, B. J. A., Alkilani, A. Z., Al-Adhami, Y., & Obaidat, R. (2024). Recent Advances in Microneedling-Assisted Cosmetic Applications. Cosmetics, 11(2), 51. https://doi.org/10.3390/cosmetics11020051
  64. Bae, J. S., Nam, S. M., Cha, H. G., & Park, E. S. (2022). A split-face study to evaluate the efficacy of a dissolving microneedle-encapsulated niacinamide skin patch for the reduction of facial hyperpigmentation. Archives of Aesthetic Plastic Surgery, 28(4), 113–118. https://doi.org/10.14730/aaps.2022.00633
  65. Kang, H., Zuo, Z., Lin, R., Yao, M., Han, Y., & Han, J. (2022). The most promising microneedle device: present and future of hyaluronic acid microneedle patch. Drug Delivery, 29(1), 3087–3110. https://doi.org/10.1080/10717544.2022.2125600
  66. Wang, Q., Gan, Z., Wang, X., Li, X., Zhao, L., Li, D., Xu, Z., Mu, C., Ge, L., & Li, D. (2024). Dissolving Hyaluronic Acid-Based Microneedles to Transdermally Deliver Eugenol Combined with Photothermal Therapy for Acne Vulgaris Treatment. ACS Applied Materials & Interfaces, 16(17), 21595–21609. https://doi.org/10.1021/acsami.4c01790
  67. Nair, P., &Tandel, J. (2021). Microneedling: A means of collagen induction therapy. Journal of Dermatology & Dermatologic Surgery, 25(2), 49. https://doi.org/10.4103/jdds.jdds_126_20
  68. Yamagishi, R., Miura, S., Yabu, K., Ando, M., Hachikubo, Y., Yokoyama, Y., Yasuda, K., & Takei, S. (2024). Fabrication Technology of Self-Dissolving Sodium Hyaluronate Gels Ultrafine Microneedles for Medical Applications with UV-Curing Gas-Permeable Mold. Gels, 10(1), 65. https://doi.org/10.3390/gels10010065
  69. Rajput, A., Patil, A., Kandhare, P., &Pawar, A. (2024). Application of Microneedle Arrays in Cosmetics: Promises, Advances, and Challenges. Medicine in Novel Technology and Devices, 100325. https://doi.org/10.1016/j.medntd.2024.100325
  70. Kang, G., Tu, T. N. T., Kim, S., Yang, H., Jang, M., Jo, D., Ryu, J., Baek, J., & Jung, H. (2018). Adenosine  loaded dissolving microneedle patches to improve skin wrinkles, dermal density, elasticity and hydration. International Journal of Cosmetic Science, 40(2), 199–206. https://doi.org/10.1111/ics.12453
  71. Ahmad, Z., Khan, M. I., Siddique, M. I., Sarwar, H. S., Shahnaz, G., Hussain, S. Z., Bukhari, N. I., Hussain, I., & Sohail, M. F. (2020). Fabrication and Characterization of Thiolated Chitosan Microneedle Patch for Transdermal Delivery of Tacrolimus. AAPS PharmSciTech, 21(2). https://doi.org/10.1208/s12249-019-16119
  72. Anwar, I., Zafar, N., Mahmood, A., Zulcaif, Z., & Latif, R. (2024). Sustained release microneedle patch for pronounced systemic delivery of doxazosin mesylate. Bioimpacts. https://doi.org/10.34172/bi.30257
  73. Permana, A. D., Paredes, A. J., Volpe-Zanutto, F., Anjani, Q. K., Utomo, E., & Donnelly, R. F. (2020). Dissolving microneedle-mediated dermal delivery of itraconazole nanocrystals for improved treatment of cutaneous candidiasis. European Journal of Pharmaceutics and Biopharmaceutics, 154, 50–61. https://doi.org/10.1016/j.ejpb.2020.06.025
  74. He, H., Wang, Z., Aikelamu, K., Bai, J., Shen, Q., Gao, X., & Wang, M. (2023). Preparation and In Vitro Characterization of Microneedles Containing Inclusion Complexes Loaded with Progesterone. Pharmaceutics, 15(6), 1765. https://doi.org/10.3390/pharmaceutics15061765
  75. McCrudden, M. T., Alkilani, A. Z., McCrudden, C. M., McAlister, E., McCarthy, H. O., Woolfson, A. D., & Donnelly, R. F. (2014b). Design and physicochemical characterisation of novel dissolving polymeric microneedle arrays for transdermal delivery of high dose, low molecular weight drugs. Journal of Controlled Release, 180, 71–80. https://doi.org/10.1016/j.jconrel.2014.02.007
  76. Ananda, P. W. R., Elim, D., Zaman, H. S., Muslimin, W., Tunggeng, M. G. R., &Permana, A. D. (2021). Combination of transdermal patches and solid microneedles for improved transdermal delivery of primaquine. International Journal of Pharmaceutics, 609, 121204. https://doi.org/10.1016/j.ijpharm.2021.121204
  77. Li, Y., Liu, F., Su, C., Yu, B., Liu, D., Chen, H., Lin, D., Yang, C., Zhou, L., Wu, Q., Xia, W., Xie, X., & Tao, J. (2019b). Biodegradable Therapeutic Microneedle Patch for Rapid Antihypertensive Treatment. ACS Applied Materials & Interfaces, 11(34), 30575–30584. https://doi.org/10.1021/acsami.9b09697
  78. Ameri, M., Kadkhodayan, M., Nguyen, J., Bravo, J., Su, R., Chan, K., Samiee, A., &Daddona, P. (2014). Human Growth Hormone Delivery with a Microneedle Transdermal System: Preclinical Formulation, Stability, Delivery and PK of Therapeutically Relevant Doses. Pharmaceutics, 6(2), 220–234. https://doi.org/10.3390/pharmaceutics6020220
  79. Pamornpathomkul, B., Ngawhirunpat, T., Tekko, I. A., Vora, L., McCarthy, H. O., & Donnelly, R. F. (2018). Dissolving polymeric microneedle arrays for enhanced site-specific acyclovir delivery. European Journal of Pharmaceutical Sciences, 121, 200–209. https://doi.org/10.1016/j.ejps.2018.05.009
  80. Bhatnagar, S., Saju, A., Cheerla, K. D., Gade, S. K., Garg, P., & Venuganti, V. V. K. (2017). Corneal delivery of besifloxacin using rapidly dissolving polymeric microneedles. Drug Delivery and Translational Research, 8(3), 473–483. https://doi.org/10.1007/s13346-017-0470-8
  81. Alwan LA, Al-Akkam EJ. Formulation and Evaluation of Transdermal Dissolved Microneedles Patches for Meloxicam. International Journal of Drug Delivery Technology. 2021;11(3):656-662.
  82. Surekha, B., Misra, P., Thippaiah, A. C., Shamanna, B. R., Madathil, A., &Rajadurai, M. (2024). A Microneedle Transdermal Patch loaded with Iron(II) Nanoparticles for Non-invasive Sustained Delivery to Combat Anemia. Materials Advances. https://doi.org/10.1039/d3ma01166f
  83. Kumar, M. K., Inamadar, A. C., & Palit, A. (2018). A randomized controlled, single-observer blinded study to determine the efficacy of topical minoxidil plus microneedling versus topical minoxidil alone in the treatment of androgenetic alopecia. Journal of Cutaneous and Aesthetic Surgery, 11(4), 211. https://doi.org/10.4103/jcas.jcas_130_17
  84. McAlister, E., Kearney, MC., Martin, E.L. et al. From the laboratory to the end-user: a primary packaging study for microneedle patches containing amoxicillin sodium. Drug Deliv. and Transl. Res. 11, 2169–2185 (2021). https://doi.org/10.1007/s13346-020-00883-5
  85. Li, Y., Vora, L. K., Wang, J., Sabri, A. H. B., Graham, A., McCarthy, H. O., & Donnelly, R. F. (2024). Poly(acrylic acid)/Poly(vinyl alcohol) Microarray Patches for Continuous Transdermal Delivery of Levodopa and Carbidopa: In Vitro and In Vivo                                    Studies. Pharmaceutics,        16(5), 676. https://doi.org/10.3390/pharmaceutics16050676
  86. Wang, C., Huang, X., Tang, Z., Zhang, Y., Wei, M., Du, S., Song, X., Wu, Y., Chi, Q., Zhuang, X., Lina, D., & Jin, Y. (2024). Dissolving microneedles loaded with nimodipine for prevention of sleep disorders at a high altitude. Pharmaceutical Development and Technology, 29(5), 415–428. https://doi.org/10.1080/10837450.2024.2342965
  87. Al-Shaibani, A. J. N., & Ghareeb, M. M. (2024). Formulation, in vitro and in vivo evaluation of olanzapine nanoparticles dissolving microneedles for transdermal delivery. Pharmacia, 71, 1–13. https://doi.org/10.3897/pharmacia.71.e120974
  88. Rapoport, A. M., Ameri, M., Lewis, H., & Kellerman, D. J. (2020). Development of a novel zolmitriptanintracutaneous microneedle system (QtryptaTM) for the acute treatment of migraine. Pain Management, 10(6), 359–366. https://doi.org/10.2217/pmt-2020-0041
  89. Zhang, T., Sun, B., Guo, J., Wang, M., Cui, H., Mao, H., Wang, B., & Yan, F. (2020). Active pharmaceutical ingredient poly(ionic liquid)-based microneedles for the treatment of skin acne infection. ActaBiomaterialia, 115, 136–147. https://doi.org/10.1016/j.actbio.2020.08.023
  90. Sim, J., Kang, G., Yang, H., Jang, M., Kim, Y., Ahn, H., Kim, M., & Jung, H. (2022). Development of Clinical Weekly-Dose Teriparatide Acetate Encapsulated Dissolving Microneedle Patch for Efficient Treatment of Osteoporosis. Polymers, 14(19), 4027. https://doi.org/10.3390/polym14194027
  91. Koutsonanos, D. G., Compans, R. W., &Skountzou, I. (2013). Targeting the Skin for Microneedle Delivery of Influenza Vaccine. Advances in Experimental Medicine and Biology, 121–132. https://doi.org/10.1007/978-1-4614-6217-0_13
  92. Li, G., Badkar, A., Nema, S., Kolli, C. S., &Banga, A. K. (2008). In vitro transdermal delivery of therapeutic antibodies using maltose microneedles. International Journal of Pharmaceutics, 368(1–2), 109–115. https://doi.org/10.1016/j.ijpharm.2008.10.008
  93. Aich, K., Singh, T., & Dang, S. (2021). Advances in microneedle-based transdermal delivery for drugs and peptides. Drug Delivery and Translational Research, 12(7), 1556–1568. https://doi.org/10.1007/s13346-02101056-8
  94. Kirkby, M., Hutton, A. R., & Donnelly, R. F. (2020). Microneedle Mediated Transdermal Delivery of Protein, Peptide and Antibody Based Therapeutics: Current Status and Future Considerations. Pharmaceutical Research, 37(6). https://doi.org/10.1007/s11095-020-02844-6
  95. Sun, W., Inayathullah, M., Manoukian, M. a. C., Malkovskiy, A. V., Manickam, S., Marinkovich, M. P., Lane, A. T., Tayebi, L., Seifalian, A. M., & Rajadas, J. (2015). Transdermal Delivery of Functional Collagen Via Polyvinylpyrrolidone Microneedles. Annals of Biomedical Engineering, 43(12), 2978–2990. https://doi.org/10.1007/s10439-015-1353-0
  96. Lee, Y., Kumar, S., Kim, S. H., Seong, K., Lee, H., Kim, C., Jung, Y., & Yang, S. Y. (2020). Odorless Glutathione Microneedle Patches for Skin Whitening. Pharmaceutics, 12(2), 100. https://doi.org/10.3390/pharmaceutics12020100
  97. Shin, C. I., Kim, M., & Kim, Y. (2019b). Delivery of Niacinamide to the Skin Using Microneedle-Like Particles. Pharmaceutics, 11(7), 326. https://doi.org/10.3390/pharmaceutics11070326
  98. Hiraishi, Y., Nakagawa, T., Quan, Y., Kamiyama, F., Hirobe, S., Okada, N., & Nakagawa, S. (2012). Performance and characteristics evaluation of a sodium hyaluronate-based microneedle patch for a transcutaneous drug delivery system. International Journal of Pharmaceutics, 441(1–2), 570–579. https://doi.org/10.1016/j.ijpharm.2012.10.042
  99. Feng, X., Su, H., &Xie, J. (2023). The efficacy and safety of microneedling with topical tranexamic acid for melasma treatment: A systematic review and meta analysis. Journal of Cosmetic Dermatology, 23(1), 33–43. https://doi.org/10.1111/jocd.15965
  100. Khorshidian, A., Sharifi, N., Kheirabadi, F. C., Rezaei, F., Sheikholeslami, S. A., Ariyannejad, A., Esmaeili, J., Basati, H., &Barati, A. (2024). In Vitro Release of GlycyrrhizaGlabra Extract by a Gel-Based Microneedle Patch for Psoriasis Treatment. Gels, 10(2), 87. https://doi.org/10.3390/gels10020087
  101. Ding Zhi, Liu Yang, & Zhang Junfeng. (2020, January 19). CN113133991B - Colchicine soluble microneedle patch and preparation method thereof   - Google Patents.  https://patents.google.com/patent/CN113133991B/en
  102. Zhang Yanfeng, Chen Yongli, Zhang Kaimin, Gan Miao, GuLihong, Zou Zhirong, Huang Weilin,& Ltd, S. U. B. C. (2023, February 8).CN116270666A – Patch for treating dermatophyte infection and preparation method thereof - Google Patents. https://patents.google.com/patent/CN116270666A/en?oq=CN116270666A
  103. Xia Denning, Lin Hongbing, & Pei Dandi. (2023, February 28). CN116350751A - Liraglutide microneedle patch and preparation method and application thereof  - Google Patents. https://patents.google.com/patent/CN116350751A/en?oq=CN116350751A 
  104. Lin Xiaoxi, Zhang Shiren, QiuYajing, & Liu Yun. (2023, April 11). CN116421874A - Soluble microneedle patch carrying anti-hemangioma drug and preparation method thereof   - Google Patents. https://patents.google.com/patent/CN116421874A/en?oq=CN116421874A 
  105. Baek Kyeong-rae, Choi Jae-min, &Dermajec. (2023, January 10). KR102563820B1 - A microneedle for brightening which stabilizes vitamin c or derivatives thereof using antioxidant-network,substances-Google-Patents. https://patents.google.com/patent/KR102563820B1/en?oq=KR102563820B1
  106. Ding Xin, Liang Yijing, & Yuan Peiyan. (2023, April 27). CN116617150A - Antifungal microneedle patch and preparation method and application thereof   - Google Patents. https://patents.google.com/patent/CN116617150A/en?oq=CN116617150A
  107. Shuai Xintao, Wang Jiachen, Huang Sicong, Wei Huiye, & Lin Minzhao(2023, July 24). CN116687833A - Soluble microneedle containing antibody-coupled albumin taxolnano-drug and preparation method and application thereof   - Google Patents. https://patents.google.com/patent/CN116687833A/en?oq=CN116687833A 
  108. Xing Chengfen, Zhang Ran, Li Hao, & Zhan Yong. (2023, July 25). CN116725939A - Soluble hyaluronic acid drugloadedmicroneedle and preparation method thereof  - Google Patents. https://patents.google.com/patent/CN116725939A/en?oq=CN116725939A
  109. Chen Xuheng, Wan Guoyun, Gou Ruiling, Chen Hongli, Wang Haijiao, Li Yaojia, Chang Jiaxin, Chen Jiayu, Li Xiaoyu, & Guan Chenguang. (2023, July 24). CN116763715A - Preparation method and application of paeonol-soluble transdermal microneedle for treating psoriasis-Google-Patents.  https://patents.google.com/patent/CN116763715A/en?oq=CN116763715A
  110. Du Jie, Wang Yuan, GuoXindong, Li Dehui, & He Yuting. (2023, June 15). CN116440062B - Soluble microneedle patch carrying levosimendan for treating heart failure and preparation method,thereof-Google-Patents. https://patents.google.com/patent/CN116440062B/en?oq=CN116440062B
  111. Henke, S., Henning, A., Pracht, R., Brodkorb, D., Scherr, S., & Ag, L. L. T. S. (2018b, April 19).  US20230330010A1 - Microneedle system for the delivery of interferon   - Google Patents.  https://patents.google.com/patent/US20230330010A1/en?oq=US20230330010A1 
  112. Qu Yan, Yang Qin, ZhongGuofeng, Zhang Chen, Zeng Rui, Gou Kaijun, & Wang Xiao. (2023, August 21). CN116763716A - Bletilla polysaccharide microneedle carrying ginsenoside Rg3 and preparation method and application thereof - Google Patents. https://patents.google.com/patent/CN116763716A/en?oq=CN116763716A 
  113. Wang Mei, Shen Qi, & He Hongji.(2023, August 22). CN117018422A - Preparation method of progesterone liposome slow release microneedle  - Google Patents. https://patents.google.com/patent/CN117018422A/en?oq=CN117018422A
  114. Qian Haisheng, Zheng Wang, Chu Zhaoyou, Wang Wanni, Xu Linling, Ma Yan, & Wang Peisan. (2023, November 10). CN117258131A - Microneedle patch loaded with sparfloxacin and manganese-based nanodrugs and application of microneedle patch in-situ triple negative breast cancer and lung metastasis treatment   - Google Patents. https://patents.google.com/patent/CN117258131A/en?oq=CN117258131A
  115. Li Wei, Chen Chuang, Zhang Wen, &JinYinli. (2023, October 30). CN117503682A - Levothyroxine sodiumloaded microcrystalline biphasic microneedle patch for treating hypothyroidism by combining mussel-like adhesion material, and preparation method and application thereof    - Google Patents. https://patents.google.com/patent/CN117503682A/en?oq=CN117503682A
  116. Su Qing, Tang Shuai, Su Xiaomeng, Xu Fengqian, & Sun Tong. (2023, December 11). CN117598988A - Dutasteride nano suspension, soluble microneedle and preparation method thereof   - Google Patents. https://patents.google.com/patent/CN117598988A/en?oq=CN117598988A
  117. Mira Jo, Joong-ho Lee, Sun-young Lee, A-ram Lee, Jeong-won Choi, Hyun-sik Na, Geun-hyeong Cho, Chaerim Lee, Su-bin Jeon, & Industry-Academic Cooperation Unit(2023, January 26). KR20240117782A - Composition for skin patch and injection treatment for keloid,treatment-Google-Patents. https://patents.google.com/patent/KR20240117782A/en?oq=KR20240117782A
  118. Gou Maling, & Jiang Xuebing.(2023, March 10). CN118615229A - Lidocaine hydrochloride microneedle patch, preparation method thereof and application of isomaltulose alcohol in microneedle,patch-Google-Patents. https://patents.google.com/patent/CN118615229A/en?oq=CN118615229A
  119. Wang, L., &Cotsarelis, G. (2023, March 8). WO2024187056A2 - Minoxidil-crosslinked injectable hydrogels for local and sustained intradermal delivery   - Google Patents. https://patents.google.com/patent/WO2024187056A2/en?oq=WO2024187056A2
  120. Fakih, H. H., Sleiman, H., Khvorova, A., Tang, Q., Harris, J. E., Alterman, J. F., Abideen, M. Z. U., & Furgal, R. (2023, March 3). WO2024186627A1 - Topical delivery of therapeutic oligonucleotides    - Google Patents. https://patents.google.com/patent/WO2024186627A1/en?oq=WO2024186627A1.

Photo
Shaikh Shama
Corresponding author

Anjuman-I-Islam Kalsekar Technical Campus/India.

Photo
Kadam Snehal
Co-author

Anjuman-I-Islam Kalsekar Technical Campus/India.

Photo
Kasu Daniya
Co-author

Anjuman-I-Islam Kalsekar Technical Campus/India.

Photo
Momin Ishrat
Co-author

Anjuman-I-Islam Kalsekar Technical Campus/India.

Photo
Khan Sharina
Co-author

Anjuman-I-Islam Kalsekar Technical Campus/India.

Photo
Poonam Patil
Co-author

Anjuman-I-Islam Kalsekar Technical Campus/India.

Kadam Snehal, Kasu Daniya, Momin Ishrat, Shaikh Shama*, Khan Sharina, Poonam Patil, Microneedle Technology: A Revolutionary Approach to Drug Delivery, Int. J. of Pharm. Sci., 2025, Vol 3, Issue 4, 106-139 https://doi.org/10.5281/zenodo.15119727

More related articles
A Review: Recent Trend on Novel Drug Delivery Syst...
Srushti Mali, Divya Malviya, Gaurav Marathe, Meenaz Sayyed, Ravin...
Innovations In Oral Drug Administration: Exploring...
VIGNESH . R, Kamaleshwari B., Kaviya G., Kovarthanan M., Mohan Ra...
A Review: Recent Trend on Novel Drug Delivery Syst...
Srushti Mali, Divya Malviya, Gaurav Marathe, Meenaz Sayyed, Ravin...
A Review on Modern Treatment Approach-Nanogel Against Bacterial Conjuctivitis ...
Manoj S., Dr. Beny Baby, Dr. S. Rajarajan, Akhilesh Kumar Yadav, ...
Innovations In Oral Drug Administration: Exploring Gastro Retentive Raft Forming...
VIGNESH . R, Kamaleshwari B., Kaviya G., Kovarthanan M., Mohan Raj U., ...
Innovations In Oral Drug Administration: Exploring Gastro Retentive Raft Forming...
VIGNESH . R, Kamaleshwari B., Kaviya G., Kovarthanan M., Mohan Raj U., ...
Related Articles
A Review on Modern Treatment Approach-Nanogel Against Bacterial Conjuctivitis ...
Manoj S., Dr. Beny Baby, Dr. S. Rajarajan, Akhilesh Kumar Yadav, ...
A Review: Recent Trend on Novel Drug Delivery System...
Srushti Mali, Divya Malviya, Gaurav Marathe, Meenaz Sayyed, Ravindra Patil, ...
Innovations In Oral Drug Administration: Exploring Gastro Retentive Raft Forming...
VIGNESH . R, Kamaleshwari B., Kaviya G., Kovarthanan M., Mohan Raj U., ...
A Review: Recent Trend on Novel Drug Delivery System...
Srushti Mali, Divya Malviya, Gaurav Marathe, Meenaz Sayyed, Ravindra Patil, ...
A Review: Recent Trend on Novel Drug Delivery System...
Srushti Mali, Divya Malviya, Gaurav Marathe, Meenaz Sayyed, Ravindra Patil, ...
More related articles
A Review: Recent Trend on Novel Drug Delivery System...
Srushti Mali, Divya Malviya, Gaurav Marathe, Meenaz Sayyed, Ravindra Patil, ...
Innovations In Oral Drug Administration: Exploring Gastro Retentive Raft Forming...
VIGNESH . R, Kamaleshwari B., Kaviya G., Kovarthanan M., Mohan Raj U., ...
A Review: Recent Trend on Novel Drug Delivery System...
Srushti Mali, Divya Malviya, Gaurav Marathe, Meenaz Sayyed, Ravindra Patil, ...
A Review: Recent Trend on Novel Drug Delivery System...
Srushti Mali, Divya Malviya, Gaurav Marathe, Meenaz Sayyed, Ravindra Patil, ...
Innovations In Oral Drug Administration: Exploring Gastro Retentive Raft Forming...
VIGNESH . R, Kamaleshwari B., Kaviya G., Kovarthanan M., Mohan Raj U., ...
A Review: Recent Trend on Novel Drug Delivery System...
Srushti Mali, Divya Malviya, Gaurav Marathe, Meenaz Sayyed, Ravindra Patil, ...